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S-nitrosothiol modifications of proteins are emerging as an important nitric oxide-mediated 
signaling pathway.  Our laboratory has focused on S-nitrosation of the metal binding protein 
metallothionein and the resulting effects on zinc homeostasis, gene and protein expression and 
nitric oxide (NO) mediated signaling in the pulmonary endothelium.  Statement of public health 
significance:  The pulmonary endothelium is responsible for filtering the blood before it enters 
systemic circulation, and as such it is extremely vulnerable to injury by inhaled toxicants in the 
environment as well as those that circulate in the bloodstream.  As the endothelium constitutively 
produces NO, we are interested in studying NO-mediated signaling in order to lay a foundation 
that will allow us to better understand diseases such as asthma, pulmonary hypertension and 
sepsis in which dysregulation of NO-mediated signaling is thought to be a contributing factor to 
the disease pathology.   
To this end we have used both recombinant DNA and biochemical techniques to examine 
the relationship between metallothionein, zinc homeostasis and the metal responsive 
transcription factor MTF-1.  We demonstrated that exposure to NO results in zinc release from 
metallothionein, which in turn activates MTF-1, resulting in nuclear translocation of the protein 
and NO-dependent increases in metallothionein protein expression.  We hypothesized that S-
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nitrosation of the sulphydryl groups in metallothionein were the cause of NO-mediated zinc 
release and downstream protein expression effects.  We used a fluorescent modification of the 
biotin switch assay in combination with two-dimensional electrophoresis and mass spectroscopy 
to extend our study of NO-mediated signaling through S-nitrosation of protein thiols to identify 
S-nitrosated metallothionein in endothelial cells exposed to NO donor, and used the technique in 
further studies to illuminate the proteome of pulmonary endothelial cells.  We were able to 
identify several potential targets of S-nitrosation in endothelial cells including cytoskeletal, 
cytoprotective, glycolytic and chaperone proteins.  The proteomic assay that we developed is a 
useful screening tool, and may lead to new insights in post-translational S-nitrosothiol 
modifications of endothelial proteins, and eventually to new perspectives regarding diseases 
exacerbated by dysregulation of this NO-mediated signaling pathway.  
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1.0  CHAPTER 1:  INTRODUCTION 
Nitric oxide is a gaseous, free radical molecule produced by nitric oxide synthase (NOS) that 
regulates a large number of biological functions including vasodilation, neurotransmission, 
inflammation and cell death [1]. Our goal in the following studies has been to examine the 
potential role of NO as a signaling molecule in the pulmonary endothelium.  In our studies we 
have used a combination of molecular cloning, imaging and biochemical techniques to examine 
the potential connections between the low-molecular weight, thiol-rich protein metallothionein 
(MT), NO, and zinc homeostasis in the endothelium.  We expanded upon these studies to screen 
cultured primary endothelial cells for proteins that may be involved in an emerging nitric oxide-
mediated signaling pathway involving S-nitrosation of protein thiols.  In order to complete this 
screening, we made modifications to an accepted S-nitrosothiol detection technique. 
1.1 NITRIC OXIDE-MEDIATED SIGNALING IN THE PULMONARY 
ENDOTHELIUM AND PUBLIC HEALTH 
Endothelial cells comprise the lining of all blood vessels.  In the human lung, which has the 
largest combined endothelial/epithelial surface areas of any organ, the endothelium has a surface 
area of approximately 130 m2 [2; 3].  The primary functions of the endothelium are to promote 
anti-aggregation, serve as a barrier, and to synthesize, metabolize or take up vasoactive 
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compounds [4].  As such, the pulmonary endothelium comes into contact with the entire contents 
of circulating blood as well as being exposed to any inhaled particles or toxicants.  Toxicological 
insults to the endothelial layer as well as clinical disorders such as sepsis, and pneumonia can 
lead to acute lung injury [5].  Symptoms of acute lung injury include severe respiratory distress 
and hypoxia [4].  In certain cases acute lung injury may progress to a more severe form of 
disease, acute respiratory distress syndrome, which is characterized by development of 
pulmonary edema, and increases in both reactive oxygen and reactive nitrogen species.  It is 
estimated that acute respiratory distress syndrome may account for up to 36 000 deaths per year 
in industrialized nations [6].  It is known that production of reactive oxygen and nitrogen species 
is increased in acute respiratory distress syndrome, and that one source of reactive nitrogen 
species is the pulmonary endothelium itself [7].  There is histochemical evidence of reactive 
nitrogen species-based protein modifications in samples from the lungs of acute respiratory 
distress syndrome patients [7; 8].  It has also been shown that NO can attenuate leakage in the 
lungs of patients with acute respiratory distress syndrome, and that therapeutic inhaled NO can 
abate hypoxia in both animal models and human studies [9].   
It is known that sepsis is the most significant risk factor for development of acute lung 
injury or acute respiratory distress syndrome [10; 11]. The mortality rate for sepsis ranges from 
15% to >60% in septic shock [12]. It has been demonstrated that NO production in endothelial 
cells is increased in sepsis, perhaps through expression of iNOS [13; 14; 15; 16; 17].  Increased 
NO production may explain the drop in blood pressure observed in sepsis [18] that can be 
reversed with NOS inhibitors [19; 20; 21].  In addition increased NO production may lead to the 
formation of peroxynitrite (ONOO-).  Decomposition of ONOO- into peroxide radicals (HO•) 
may result in endothelial cell death [22]. However, it has also been demonstrated that exposure 
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to low levels of NO can inhibit LPS-induced apoptosis [23; 24; 25; 26].  It has been speculated 
that suppression of LPS-induced apoptosis occurs through inactivation of caspase-3 [23; 26], 
which has been demonstrated to be S-nitrosated at a critical catalytic residue [27; 28; 29].  
However the endothelial signaling pathways that are involved in acute lung injury and acute 
respiratory distress syndrome are incompletely understood and the development of new 
screening tools to examine potential dysregulation of S-nitrosothiol-based signaling would be 
extremely valuable in dissecting the mechanisms that lead to onset and progression of injury.   
In addition to potential involvement in sepsis and acute lung injury, it has been suggested 
that dysregulation of NO-mediated signaling pathways is involved in many other diseases [30].  
Asthma is one such disease.  In an ovalbumin-sensitization animal model of asthma, metabolism 
of S-nitrosoglutathione (GSNO) is increased leading to low levels of GSNO in the airway lining 
fluid [31].  Indeed, levels of GSNO in the airway lining fluid of human asthma patients are low, 
even though conditions would be expected to favor S-nitrosothiol formation [32; 33].  In 
addition, in pulmonary hypertension investigators found levels of S-nitrosohemoglobin to be 
reduced relative to normal controls [30].  From these selected examples, it is clear that 
dysregulation of S-nitrosothiol homeostasis contributes to disease states and that a tool for 
examining the spectrum of S-nitrosation in pulmonary endothelial cells would be very useful. 
1.2 CELLULAR PRODUCTION OF NITRIC OXIDE 
NO plays a variety of roles in biological systems and is produced in various cell types by an 
enzyme, nitric oxide synthase (NOS).  All NOS isoforms catalyze the five-electron oxidation of 
the terminal nitrogen of arginine, using NADPH, flavins, tetrahydrobiopterin, and thiol as co-
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factors, ultimately producing nitric oxide (NO) and citrulline [34].  It is believed that successive 
activation of two O2 molecules by the heme moiety of NOS is needed to insert a pair of oxygen 
atoms into arginine and yield NO [34].  It is also known that under certain cellular redox 
conditions NOSs can produce NO- [34].   
 The first isoform, eNOS, is constitutively expressed primarily in endothelial cells in the 
vasculature, and the nitric oxide synthesized results in vasorelaxation [35].  The second isoform, 
nNOS, is constitutively expressed in the nervous system where it functions as a neurotransmitter 
[36].  Finally, iNOS expression is induced in macrophages as a protective mechanism in 
inflammation in the immune system [36].  Since our studies have focused on signaling in the 
endothelium, it is necessary to touch upon the regulation of NO production in eNOS. 
 There are three known levels of regulation for eNOS; 1) the interaction of eNOS with 
proteins such as caveolin and Ca2+/calmodulin, 2) the phosphorylation state of the enzyme and, 
3) the differential location of the enzyme within the cell [37].  eNOS seems to be regulated 
differently depending upon its subcellular location.  At the plasma membrane, Ca2+/calmodulin 
regulates eNOS, whereas in the Golgi regulation occurs mainly through Akt [38].  Within the 
cell, trafficking of eNOS appears to be dependent upon the actin cytoskeleton in addition to 
interactions with proteins such as eNOS-trafficking inducer (NOSTRIN) and caveolin [37]. 
 It is also known that interactions of eNOS with the cellular cytoskeleton, particularly 
actin microfilaments, are essential for shear stress-mediated NO production [39].  eNOS protein 
interacts directly with the actin cytoskeleton, and disruption of this interaction via changes in the 
cytoskeletal structure during shear stress results in an increase in eNOS mRNA half-life and 
ultimately in increased NO production [39].   
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1.3 BIOCHEMISTRY OF NITRIC OXIDE 
Upon synthesis by NOS, NO chemistry involves a number of redox forms: nitrosonium cation 
(NO+), nitric oxide (NO•), which is a free radical species, and the nitroxyl anion (NO-) [34].  NO 
is a paramagnetic molecule with a single, unpaired electron in its 2p-π orbital (Figure 1.1) [40]. 
 
N::O• 
Figure 1-1 Nitric oxide is a paramagnetic molecule.  Its unique biochemical properties can be attributed to 
the presence of a single, unpaired electron in the 2p-π orbital. 
 
Addition of an electron to NO leads to formation of NO- while loss of an electron results in 
formation of NO+ [34].  NO reacts quite readily with oxygen (O2) and superoxide (O2•) to form 
various nitrosocompounds and peroxynitrite (ONOO-) [34].  NO can also react with transition 
metals including heme moieties.  Reaction of NO with heme results in formation of an iron-
nitrosyl complex.  Upon binding the Fe(III)NO•- heme undergoes a charge transfer to form 
Fe(II)NO+ making the NO+ moiety available for attack by cellular nucelophiles [41].  This 
property allows NO-transition metal complexes to function as effective “carriers” of NO+ in the 
cell [34].  Upon formation of an NO+ equivalent various cellular nucleophiles such as amines and 
thiols may attack the NO+ and become nitrosated.  Under physiological conditions S-nitrosation  
(the addition of a NO+ moiety to a thiol) is favored over N-nitrosation (the addition of a NO+ 
moiety to an amine) due to the existence of amines primarily in their unreactive, protonated form 
[42].  In addition S-nitrosation is favorable due to the lower rate of hydrolysis of S-nitrosothiols 
as compared to nitrosamines [42].  The second redox species of NO, NO-, is known to be 
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converted to N2O in aqueous solution, react with Fe(III) heme, and to oxidize cellular thiols, 
ultimately resulting in the formation of disulfides [34].   
1.4 METALLOTHIONEIN, NITRIC OXIDE AND ZINC HOMEOSTASIS 
Metallothioneins (MT) are small (6 kDa), cysteine-rich, heavy metal binding proteins [43] 
(Figure 1.2).  There are four known MT isoforms in mice, each with a particular expression 
pattern.  MT-I and MT-II are expressed in the central nervous system and stratified squamous 
epithelium, respectively [44] and these isoforms account for most of the effects of MT.  Several 
functions have been suggested for MT including detoxification of heavy metals, regulation of 
copper and zinc homeostasis and protection from oxidative damage [45; 46].  There is in vitro 
data to support the suggestion that MT forms a link between cellular redox state and metal ion 
homeostasis [47; 48; 49; 50; 51; 52; 53].  
 
Figure 1-2 Metallothionein.  Metallothionein contains 61 amino acid residues, 20 of which are cysteines.  
It can bind 7 divalent metal atoms, 3 in the N terminal or alpha cluster and 4 in the C terminal or beta cluster.  In this 
image cysteine residues are represented in yellow and metal ions in blue [54]. 
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There is evidence that MT can react with NO forming iron-dinitrosyl-sulfur complexes 
that can be detected using electron paramagnetic resonance (EPR) [54; 55].  In addition there is 
evidence that exposure to NO can result in the release of metals such as cadmium [56], copper 
[57; 58], and zinc [59; 60; 61; 62].  Our laboratory has focused on interactions between NO and 
MT in the vascular endothelium.  We have used various techniques to study this interaction 
including the use of an MT fusion protein consisting of MT sandwiched between cyan and 
yellow fluorescent protein and fluorescence resonance energy transfer (FRET) and various Zn-
specific fluorophores [60; 61; 62].  In these studies we demonstrated that exposure to NO caused 
unfolding of MT [60; 61] and increases in intracellular Zn2+ concentration [62], presumably 
through S-nitrosation of thiol residues in MT.  Indeed other groups have found that the thiol 
moieties in MT can be S-nitrosated in vitro [63].  In this study we have extended our previous 
work describing the effect of MT and NO-mediated zinc homeostasis in vascular endothelial 
cells to the level of transcriptional regulation through the metal response element binding 
transcription factor, MTF-1. 
1.5 METAL RESPONSE ELEMENT BINDING TRANSCRIPTION FACTOR MTF-1, 
NITRIC OXIDE AND METALLOTHIONEIN 
MTF-1 is a highly conserved, constitutively expressed, Zn-finger protein in the Cys2-His2 family 
of transcription factors [64; 65; 66; 67].  MTF-1 is an essential molecule as knockout mice suffer 
from embryonic lethality [68].  MT-I and MT-II gene expression is dependent upon the presence 
of MTF-1 in the cell [67].  The Cys2-Hys2 zinc finger motifs are involved in both tetrahedral 
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coordination of a Zn2+ atom (Figure 1.3A), while other residues are involved in binding to the 
major groove of DNA (Figure 1.3B) [67].  MTF-1 binds to metal responsive elements (MREs) in 
promoters of zinc responsive genes [67].   
 
Figure 1-3 A representative Cys2-His2 transcription factor.  Structure of Cys2-His2 zinc fingers in a 
representative transcription factor Zif268.  A) Representation of the Cys and His residues that provide coordination 
of a Zn2+ atom B) Residues that are involved in binding to the major groove of DNA. 
 
Some of the best studied MREs are present in the MT-I and MT-II promoters.  MREs are 
often arranged in tandem in the promoters of zinc-regulated genes and contain a number of 5’-
CpG sequences [67].  Heavy metals such as zinc and cadmium stimulate nuclear translocation of 
MTF-1 in mouse and human cells.  Once in the nucleus, MTF-1 binds to MREs and activates 
transcription of target genes such as MT [66], as well as other target genes such as zinc 
transporter 1 (ZnT1) [69], gamma-glutamylcysteine synthase heavy chain [70], and placental 
growth factor [71]. 
B. 
A. 
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 It has been suggested that release of Zn by reactive oxygen or nitrogen species could 
cause activation of genes transcribed by MTF-1 and act as a novel signal transduction pathway to 
protect cells against oxidative stress [72; 73; 74].  Our laboratory has demonstrated that MT 
plays a critical role in the regulation of zinc homeostasis via interactions with NO [25; 62] (See 
Appendix A).  In addition, iNOS derived NO and NO donors have been shown to increase MT 
mRNA gene expression via intracellular zinc release [75].   
 In our current research we continued to analyze the relationship between NO-mediated 
zinc release from MT and MTF-1 activation.  We created an EGFP-MTF-1 chimeric protein to 
allow us to use imaging techniques to study MTF-1 translocation in response to exposure to NO 
donors.  We also used Western Blotting to examine changes in MTF-1 and MT protein after 
treatment with NO donors (See Chapter 2). 
1.6 THE BIOCHEMISTRY OF S-NITROSATION 
In our research we have been focused upon a particular subsection of NO biochemistry: its 
reaction with thiol groups known as S-nitrosation.  Nitrosation is defined as the covalent 
attachment of an NO group to a transition metal or a thiol [76].  The attachment of an NO group 
to a cysteine thiol is known as S-nitrosation.  S-nitrosated proteins can be detected in vivo and in 
the presence of NOS inhibitors [77; 78; 79; 80].  In most cases where the site of S-nitrosothiol 
modification has been identified for a particular protein it has been found to be a modification of 
a regulatory or active site thiol [81].  The exact biochemical mechanism of S-nitrosothiol 
formation in the cellular environment is still a subject of debate, however there are several 
widely accepted theories, which we will discuss here. 
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It is known that NO+ itself does not exist in biological systems per se.  Instead there are 
several species that can be thought of as “carriers” of NO+ in the cell.  These can be NO itself, 
nitrite, N2O3, metal-nitrosyl species or another cellular S-nitrosothiol [30].  The formation of an 
S-nitrosothiol involves the transfer of a NO+ equivalent from a “carrier” species to a cysteine 
thiol [76]. To date there has been no enzyme that has been demonstrated to be involved in the 
creation of S-nitrosothiols [81].  There have been several proteins that have been implicated in 
promotion of S-nitrosation and denitrosation reactions [82; 83; 84; 85; 86; 87; 88; 89; 90].  One 
example of a protein that can decompose S-nitrosothiols is glutathione-dependent formaldehyde 
reductase [84].  Researchers found that this enzyme, which is conserved from bacteria to 
humans, can regulate intracellular levels of both S-nitrosoglutathione (GSNO) and other protein 
S-nitrosothiols [84].  Another protein that has been demonstrated to have S-nitrosothiol reducing 
capability is protein disulfide isomerase (PDI) [87].  PDI is excreted from cells that produce NO, 
such as endothelial cells, and the reduced form of PDI is capable of denitrosating both GSNO 
and S-nitrosated PDI [87]. 
1.7 S-NITROSATION AS A NEWLY EMERGING SIGNALING PATHWAY 
S-nitrosation of protein thiols has been described as a newly emerging redox-based cellular 
signaling pathway [81].  It has been compared to protein phosphorylation albeit with several 
important differences.  S-nitrosation signaling is a cGMP-independent process and there is, as of 
yet, no specific nitrosating enzyme has been identified leading to the conclusion that S-
nitrosation a redox chemistry-mediated signaling pathway [76].  In general it is thought that the 
formation of protein S-nitrosothiols will depend upon the relative formation and colocalization of 
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reduced thiols, thiyl radicals, NO and NO+ equivalents in the cell [76].  There are several factors 
that can lend specificity to this redox reaction-based signaling pathway. 
The first possible factor that can increase the specificity of S-nitrosation reactions is the 
pKa of the thiol target [81].  It has been hypothesized that flanking acidic (Asp, Glu) and basic 
(Arg, His, Lys) residues in a protein’s primary amino acid sequence, tertiary or quaternary 
structure may contribute to changes in the target thiol’s pKa, rendering it more susceptible to S-
nitrosation [91].  There is controversy in the literature as to the relevance of the theory of an 
“acid-base motif”.  Several groups claim to have identified modified cysteine thiols using this 
motif in combination with mass spectroscopy-based methods [92; 93].  However, another group 
using a computer-learning based approach based upon the results of mass spectroscopic analysis 
failed to find a relationship between linear amino acid sequence and S-nitrosation of a specific 
protein thiol residue [94].  Therefore, it seems that if the “acid-base motif” exists, it is most 
likely based upon the presence of pKa altering residues in a protein’s tertiary or quaternary 
structure. 
Another possible mechanism leading to increased specificity of S-nitrosation involves the 
presence of hydrophobic pockets surrounding susceptible thiol residues within a protein [91].  It 
is known that reactions between NO and O2 are accelerated in hydrophobic pockets and can lead 
to increased production of NO2 and N2O3, both of which can function as NO+ equivalents [95; 
96].  There are several examples of proteins in which this mechanism is thought to be important 
in driving specificity of S-nitrosation [91; 96; 97; 98].  In a particular example, redox-driven 
conformational changes in the ryanodine receptor generate a hydrophobic pocket surrounding the 
critical cysteine residue that is modified by S-nitrosation [91; 97].   
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A third factor that may influence specificity of S-nitrosation is colocalization of the target 
protein with NOS itself.  In cases where a protein may directly interact with a NOS isoform it 
has been determined that specificity of S-nitrosothiol modifications may be increased.  One of 
the best-characterized examples of this type of interaction is that of the N-methyl-D-aspartate 
receptor (NMDAR) in neurons.  In neurons, nNOS is held at the membrane by interactions with 
various scaffold-binding proteins [99].  The NMDAR also interacts with some of these same 
proteins, bringing it into close proximity with nNOS, making the NMDAR both a source of 
nNOS activation via initiation of Ca2+ flux, and a substrate for nNOS-dependent S-nitrosation 
[77; 100]. 
Zn2+ coordinated thiols more likely targets for S-nitrosation [101; 102].  Metallothionein 
(MT), with its 20 cysteine residues capable of coordinating up to 7 divalent metal ions (including 
Zn2+) [103] makes (MT) a tempting target for S-nitrosation.  Previous studies in our laboratory 
have examined the interaction between NO and zinc release from the thiol groups in MT [60; 61; 
62].  In these previous studies we have hypothesized that S-nitrosation of the thiol residues in 
MT via exposure to NO donors is responsible for the conformational changes and zinc release 
that we observed.  In this study we have used a modification of a S-nitrosothiol detection 
technique to examine the S-nitrosation status of MT in sheep pulmonary artery endothelial cells 
(SPAEC) (See Chapter 3). 
1.8 MEASUREMENT OF S-NITROSOTHIOLS 
There are several methods available to measure S-nitrosothiols, each with its own set of 
limitations that we will discuss.  It is challenging to quantify S-nitrosothiols in biological 
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systems due to their very low in vivo levels (predicted to be in the nM range in most biological 
situations) [104], and interference from nitrite, iron-nitrosyl, and other nitroso compounds in S-
nitrosothiol detection assays [105].  In addition, S-nitrosothiols can be decomposed by thiols, 
ascorbic acid and metals, which, if present, can cause loss of signal during sample processing 
[104].   The difficulties in accurate measurements of S-nitrosothiol levels can be illustrated by 
the wide range in values (from mM amounts down to nM amounts) reported by various 
laboratories using different methods of analysis [104; 106].  Not only is it important to use the 
proper measurement technique, but also proper sample preparation is key to preserve the S-
nitrosothiols that are to be measured.  We will now discuss some of the most common 
measurement techniques along with their potential pitfalls. 
The first commonly used method to measure S-nitrosothiols involves the use of 
photolysis-chemiluminescence.  Chemiluminescent detectors use the ability of NO to react with 
ozone to generate NO2* which decays back to NO2 by releasing near-infrared radiation that can 
be detected by a photomultiplier [104].  This reaction occurs in the gas phase and it is important 
that NO and ozone are mixed in equal proportion in order to maximize the luminescence 
produced [107].  There are two commonly used methods to release NO from S-nitrosothiols, 
either photolysis or chemical reduction. 
In photolysis-chemiluminescence, high-intensity UV light in the 300-350 nm range is 
used to activate S-nitrosothiols [107].  Following activation, the S-nitrosothiol can decompose to 
free NO and a thiyl radical.  It is important to note that in photolysis experiments NO can be 
formed from nitrite present either in the sample to be analyzed or the buffers used if the pH is 
allowed to become too low, if UV light below 300 nm is used in the assay, or if thiols are present 
[107; 108].  In addition, photolysis can release NO from nitrosamine or dinitrosyl-iron 
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complexes in the sample [109].  If used properly the sensitivity of a photolysis system should be 
in the low nM-range.   
In chemical reduction assays S-nitrosothiols can be cleaved using the triiodide method or 
by using Cu+ and cysteine [110; 111].  In the triiodide method samples are pre-treated with 
acidified sulfanilamide to eliminate reactivity of nitrite in the assay [112].  A mixture of I2/I- in 
acidic conditions cleaves the S-NO bond and S-nitrosothiols are measured as the difference of 
the chemiluminescent signal of samples pre-treated with HgCl2 and untreated samples [105].  In 
the Cu+ and cysteine method the cysteine transforms all S-nitrosothiols into Cys-S-NO [110].  
The resulting NO+ equivalent is reduced by Cu+ to form NO, and remaining cysteine reduces the 
Cu2+ formed in the reaction back to Cu+ [113].   
Colorimetric assays for S-nitrosothiols are generally thought to be a relatively insensitive 
method for measurement due to the fact that the limit of detection of this assay is around 500 
nM, which is relatively close to the biological concentration of S-nitrosothiols [114].  HgCl2 is 
used to displace NO+ from the S-nitrosothiol, which is detected as nitrite by using Griess 
reagents [115]. 
There are fluorescence-based assays that use the transfer of NO+ equivalents to 4,5-
diaminofluoresceine (DAF) resulting in formation of the fluorescent compound (DAF-2T) [107].  
It is possible to use photolysis, CuCl, or CuSO4 to facilitate transfer of NO+ equivalents between 
the S-nitrosothiol and DAF.  There are some arguments that the presence of free thiols can cause 
NO and S-nitrosothiol formation from nitrite and can cause increased levels of artifactual 
fluorescence, rendering the assay inaccurate [108]. 
Mass spectrometry (MS)-based analysis of S-nitrosothiols is becoming a commonly used 
S-nitrosothiol measurement method due to its sensitivity and accuracy [104].  MS-based 
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approaches can be used in combination with liquid chromatography to directly detect the 
addition of a NO moiety to a thiol as long as the sample preparation is performed carefully [107].  
Several laboratories have used MS-based approaches to identify substituted or “switched” S-
nitrosothiols as well [77; 92; 94]. 
Finally, there is a method that has been used to detect individual S-nitrosoproteins in 
complex mixtures such as the cellular proteome.  This method was developed by Jaffrey and his 
colleagues [77; 116] and is known as the Biotin Switch Assay.   
1.9 A MODIFIED BIOTIN SWITCH METHOD FOR DETECTION OF PROTEIN S-
NITROSOTHIOLS 
In our studies we have used a modification of the original biotin switch method for S-nitrosothiol 
detection (Figure 1.4).  In the original version of the Biotin Switch method protein samples can 
contain both reactive free thiols as well as S-nitrosothiols.  The first step in the method involves 
blocking free-reactive thiols with an alkylating agent, methyl methane thiosulfonate (MMTS) in 
the presence of SDS to expose all thiols to treatment.  In the assay, if free reactive thiols are 
incompletely blocked, there can be an increase in background levels of S-nitrosothiol detection 
[117].  
One way to reduce background labeling from unblocked, free reactive thiols is to increase the 
number of blocking steps; in our case we use two blocking steps with MMTS.  The next step in 
the original protocol involves reduction of protein S-nitrosothiols using ascorbate.  However, it 
has been determined that S-nitrosothiols in proteins of various molecular weights have different 
rates of reaction with ascorbate [118]. 
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Figure 1-4 The Biotin Switch Method for detection of protein S-nitrosothiols.  The steps from the original 
assay are noted in black.  Modifications to the original assay are noted in green. 
 
It is necessary to take this into consideration in order to effectively reduce all possible S-
nitrosothiols.  Failure to reduce S-nitrosothiols leads to decreased sensitivity in the assay.  
Increasing the ascorbate concentration and incubation time is one way to ensure efficient 
reduction of S-nitrosothiols (Figure 1.4) [118].  The next step of the original assay involves 
reacting the free, reactive thiol formed from the S-nitrosothiol via reduction with ascorbate with 
a thiol specific biotin moiety, N-[6(Biotinamido)-hexyl]-3’(2’-pyridyldithio)propionamide 
(Biotin-HPDP).  In the original assay, S-nitrosated proteins are detected on a Western Blot using 
a secondary detection method such as an anti-biotin antibody or a labeled-streptavidin moiety.  
However, using secondary detection techniques complicates the use of proteomic techniques.  
Therefore in our research we replaced the Biotin-HPDP moiety with a thiol-reactant fluorophore 
(Alexa labeled maleimide, Invitrogen) in order to label S-nitrosoproteins so that they may be 
directly detected in two dimensional gel electrophoresis techniques (2DGE).  We can then 
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identify S-nitrosated proteins of interest using mass spectroscopy and peptide mass 
fingerprinting. 
 There are several caveats that must be considered when using the Biotin Switch Method 
or a modification of the method.  The first issue is that the Biotin Switch Method depends upon 
being able to identify a very small difference in the levels of S-nitrosothiols in the presence of a 
very large background of cellular thiols [117].  As an example of the potential for difficulty in 
detecting S-nitrosothiols the following scenario has been considered [117]:  If the total cellular 
thiol level is approximately 100 nmol/mg protein, then in order to be able to detect 100 pmol/mg 
S-nitrosothiol with a signal-to-noise ratio of 10:1, then 99.99% of free protein thiols need to be 
blocked. 
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2.2 INTRODUCTION 
Previous studies in our laboratory have established a link between NO exposure and zinc release 
from MT [25; 60; 61; 62; 119; 120].  We have used a fluorescent chimeric MT molecule as an 
intracellular zinc reporter [60; 61].  In this case we hypothesized that exposure to NO caused S-
nitrosation of the thiol residues in MT resulting in zinc release and conformational changes in the 
protein.  We have also used zinc specific fluorophores to examine changes in intracellular zinc 
levels [25; 61; 62; 120].  We extended these studies by examining the transcriptional control of 
zinc homeostasis through MT and the metal responsive transcription factor MTF-1.  To do this 
we created an EGFP-MTF-1 fusion protein and tracked nuclear translocation after exposure to 
NO donors.  We also examined MTF-1 nuclear and cytoplasmic protein expression with and 
without exposure to NO donors via Western Blotting.  Finally, we monitored NO donor-
dependent MT protein expression levels. 
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2.3 MANUSCRIPT AS PUBLISHED IN VASCULAR PHARMACOLOGY 
2.3.1 Abstract 
We previously showed that the major Zn-binding protein, metallothionein (MT) is a 
critical target for nitric oxide (NO) with resultant increases in labile Zn. We now show that NO 
donors also affected the activity of the metal responsive transcription factor MTF-1 that 
translocates from the cytosol to the nucleus in response to physiologically relevant increases in 
intracellular Zn and transactivates MT gene expression. Exposing mouse lung endothelial cells 
(MLEC) to ZnCl2 or the NO donor, S-Nitroso-N-acetylpenicillamine (SNAP, 200 µM), caused 
nuclear translocation of a reporter molecule consisting of enhanced green fluorescent protein 
(EGFP) fused to MTF-1 (pEGFP-MTF-1). In separate experiments, NO donors induced 
increases in MT protein levels (Western blot). In contrast, NO did not cause nuclear translocation 
of EGFP-MTF-1 in MLEC from MT knockouts, demonstrating a central role for MT in 
mediating this response. These data suggest that S-nitrosation of Zn-thiolate clusters in MT and 
subsequent alterations in Zn homeostasis are participants in intracellular NO signaling pathways 
affecting gene expression. 
2.3.2 Introduction 
Metallothionein (MT), with 20 cysteine residues, is the major zinc binding protein in 
most cells [121], and is a demonstrated molecular target for nitric oxide [59; 60; 62; 122] with 
associated changes in the intracellular concentration of labile zinc [59; 62; 75; 123]. While the 
precise nature of the NO-induced modification of MT is not clear, NO-based intermediates are 
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capable of inducing S-nitrosation of the sulphydryl groups [59; 124] resulting in loss of zinc 
from the metal binding centers of the protein [59].  The cysteines of metal thiolate clusters in MT 
can thereby confer unique redox sensitivity to an otherwise redox inert metal ligand (e.g. zinc) 
and facilitate the potential for MT to participate in intracellular signal transduction pathways via 
the regulation of intracellular zinc trafficking and homeostasis [53; 62; 75]. Zinc atoms are 
positioned at catalytic, structural and regulatory sites of enzymes (e.g. caspase-3, superoxide 
dismutase, NO synthase), transcription factors (TFIIIA) and structural proteins accounting for its 
importance in maintaining a wide variety of biological processes [51; 125], and providing a 
number of putative targets for MT-released zinc. 
MT participates in a variety of protective stress responses in addition to its role in 
regulating zinc levels and distribution within the cell. In this regard, the Zn-sensitive, metal 
response element binding transcription factor, MTF-1 plays a central role in transcriptional 
activation of the MT gene in response to heavy metals and oxidative stress [74; 126]. MTF-1 is a 
highly conserved Zn-finger protein in the Cys2His2 family of transcription factors [64; 65; 66] 
that binds and transactivates gene expression through metal responsive elements (MREs) present 
in multiple copies in the proximal promoter of the MT I and MT II genes [66] as well as other 
target genes, including those for the zinc transporter, ZnT1 [69], gamma-glutamylcysteine 
synthase heavy chain [70] and placental growth factor [71]. It has been theorized that release of 
Zn by reactive oxygen/nitrogen species and activation of genes transcribed by MTF-1 could act 
as a novel signal transduction pathway, which protects the cell from oxidative stress [72; 73; 74].  
Our original finding that MT was critical to the regulation of zinc homeostasis by NO 
[62; 120] was recently confirmed using cytokine induced increases in iNOS derived NO [75]. 
Furthermore, both iNOS-derived NO, and NO donors, were shown to increase MT mRNA gene 
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expression via intracellular zinc release [75]. In the present report, we extended these findings to 
show that NO-induced changes in labile zinc impact upon the activity of MTF-1 and increase 
expression of MT protein. Collectively, these data support a signaling pathway involving NO-
mediated release of Zn from MT, zinc-sensitive activation of MTF-1, and altered expression of 
protective genes including MT.  
2.3.3 Methods 
Materials: Plasmid pCMV-MTF1 was provided courtesy of Glen Andrews.  Cell culture 
reagents including DMEM, OptiMEM, and L-glutamine were purchased from Invitrogen.  
ENDO GRO was purchased from VEC Technologies.  SNAP was purchased from Molecular 
Probes (Eugene, OR).  The monoclonal mouse anti- metallothionein (MT) antibody was from 
Dako (Carpinteria, USA). The hydrochloride of S-nitroso-L-cysteine ethyl ester (SNCEE·HCl) 
was prepared via direct S-nitrosation of the hydrochloride of L-cysteine ethyl ester with ethyl 
nitrite, as previously described [127].  SNAP and L-SNCEE were decomposed at 37ºC for 24 
hours.  
Plasmid Construction:  The MTF-1 coding sequence was released from plasmid pCMV-
MTF-1 by digestion with NotI and the resulting 5’ and 3’ ends were filled in using the Klenow 
fragment of E.coli DNA polymerase I.  Plasmid pEGFP-C3 (Clontech) was cut with Sac I and 
the exonuclease activity of T4 polymerase was used to remove the resulting ends.  The blunt-
ended MTF-1 coding sequence was ligated into the prepared pEGFP-C3 vector using a Rapid 
Ligation Kit (Roche) resulting in pEGFP-MTF1-C3.    
Cultured sheep pulmonary artery endothelial cells (SPAEC): SPAEC were cultured from sheep 
pulmonary arteries obtained from a nearby slaughterhouse as previously described [128]. The 
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SPAECs were grown in OptiMEM (GIBCO) supplemented with 10% fetal bovine serum, 
100 U/ml penicillin, and 100 µg/ml streptomycin at 37°C in an atmosphere with 5% CO2.  
Cultured murine lung endothelial cells (MLEC): The transgenic mice (MT +/+ and MT -/-) are 
existing colonies that were imported from Australia (courtesy of Drs. A. Michlaska and A. 
Choo). MLEC were isolated by modifications to established protocols using rat anti-mouse 
CD31 (i.e. PECAM) monoclonal antibody-coated magnetic beads and characterized by panels of 
endothelial cell-specific markers [25]. MLEC were grown in low-glucose DMEM, 20% FBS, 20 
mM HEPES, 2 mM glutamine, 100U/mL penicillin, 100 µg/mL streptomycin and 200 µg.mL 
Endo Gro (VEC Technologies, Inc) at 37°C in an atmosphere with 5% CO2. 
Transgene and native protein expression: Expression of MT was quantified by Western blot, 
using commercially available monoclonal antibodies (E9; Dako) and modifications of 
established protocols [129].  Cells were harvested by trypsinizing, washed once in PBS (pH 7.4) 
and resuspended in lysis buffer (10 mM Tris, pH 7.5, 0.1% SDS, 0.1 mM EDTA, adjusted to 10 
mM DTT just before use).  The resuspended cells were disrupted by sonication and allowed to 
rest on ice for 10 minutes after which the resulting whole cell lysate was cleared by 
centrifugation at 12,000 x g for 10 minutes at 4°C.  Protein concentrations in the lysates were 
measured using the Bio Rad Protein Assay.  Approximately 30 µg of total protein was heated at 
65°C for ten minutes in 1X Kimura Buffer (0.04 M Tris, pH 8.8, 1.6% SDS, 10% glycerol).  
Samples were then incubated at room temperature, in the dark, for thirty minutes in the presence 
of 0.1 M iodoacetamide (Sigma).  Proteins were separated on a 16% Tricine gel (Novex, 
Invitrogen) and transferred to a nitrocellulose membrane.  After transfer, the membrane was 
fixed in 2% glutaraldehyde (Sigma) for 5 minutes on ice before incubation with anti-
metallothionein antibody (E9, Dako).   
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  Levels of MTF-1 were also determined by Western blotting using the monoclonal 
antibody for MTF-1 kindly provided by Dr. Glen Andrews (University of Kansas).  Whole cell 
lysates for determination of MTF-1 levels were obtained as above in the MT Western blotting 
protocol.    
Nuclear and cytosolic extracts: Cellular extracts were prepared using established 
protocols [130; 131] based on modifications of the method of Dignam [132].  After treatment, 
cells were scraped from the flask in 1 mL ice-cold PBS and collected by centrifugation at 250 x g 
for 5 min at 4°C.  Cell pellets were resuspended in 5 mL of cell lysis buffer (10 mM HEPES, pH 
7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, and 0.2 mM PMSF).  Resuspended pellets were 
centrifuged at 1500 x g for 5 minutes at 4°C.  The cells were resuspended in 2 times pcv (packed 
cell volume) of cell lysis buffer, allowed to swell on ice for 10 minutes and homogenized with 10 
strokes of a Dounce homogenizer.  Nuclei were collected by centrifugation at 3300 x g for 15 
min at 4°C.  The cytosolic supernatant was cleared by centrifugation at 75,000 x g for 1 hour at 
4°C.  The resulting supernatant was concentrated in a Microcon 3 microconcentrator by 
centrifugation at 14,000 x g for 1 hour at 4°C.  The nuclear pellet was suspended, using 6 strokes 
of a Dounce homogenizer, in 3 volumes of nuclear extraction buffer (20 mM HEPES, pH 7.9, 
1.5 mM MgCl2, 400 mM KCl, 0.5 mM DTT, 0.2 mM PMSF and 25% glycerol).  The nuclear 
suspension was stirred on ice for 30 min, and then centrifuged at 75,000 x g for 30 minutes at 
4°C to clear the suspension.  The supernatant was concentrated in a Microcon3 
microconcentrator by centrifugation at 14,000 x g for 3 hours at 4°C.  Protein concentrations 
were measured using the BioRad Protein Assay and samples were processed for Western blotting 
as described in MTF-1 blotting protocol above. 
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Determination of MTF-1 Localization: SPAEC or MLEC were plated in two-well 
chambers with coverslip bottoms (Labtek II). Cells were transfected with 50ng/well plasmid 
using Lipofectamine Plus (Gibco/BRL). Two-four hours after transfection, cells were treated 
with ZnCl2 (200 µM), S-Nitroso-N-acetylpenicillamine (SNAP, 200 µM) or L-SNCEE (1 pM) 
for two hours. For fixation, cells were treated with 4% paraformaldehyde for 5 min on ice and 
imaged using a Nikon Diaphot inverted microscope. Images were collected with a Photometrics 
charge coupled device camera with MetaMorph software. Localization of pEGFP-MTF-1 was 
classified as nuclear, cytoplasmic, or both nuclear and cytoplasmic. Means and standard 
deviations were derived from three independent experiments, each sampling a minimum of 200 
cells.     
2.3.4 Results 
2.3.4.1 EGFP-MTF-1 translocates to the nucleus in response to zinc or NO. 
We generated a reporter molecule consisting of enhanced green fluorescent protein 
(EGFP) fused to the N- terminus of MTF-1 in an effort to investigate the effects of NO on the 
subcellular localization of MTF-1 in intact cells.  SPAEC were transiently transfected with the 
EGFP-MTF-1 expression vector and examined by confocal microscopy 2 h after treatment with 
NO donors or zinc. Whereas native MTF-1 has been shown to be almost exclusively localized to 
the cytoplasm in serum-starved cells [131; 133], a considerable fraction of the protein is found in 
the nucleus under normal growth conditions [65; 133].  Consistent with these reports, EGFP-
tagged MTF-1 was detected in both the cytoplasm and nucleus of untreated cells (Fig. 2.1). 
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A. 
B. C. 
Figure 2-1 continued on next page 
   
 27 
 
Figure 2-1 SPAEC transiently transfected with EGFP-MTF-1 chimera.  Under normal conditions, the 
chimeric protein is found both in the cytosol and nucleus of the cells (panels 2.1A and 2.1B).  Upon addition of 200 
µM ZnCl2, a significant portion of the chimeric protein migrates to the nucleus (panels 2.1C and 2.1D).  After a 2 hr 
treatment with the nitric oxide donor SNAP (200 µM), the EGFP-MTF-1 chimera had migrated to the nucleus of a 
significant portion of the cells (panel 2.1D). 
 
However, nuclear accumulation of pEGFP-MTF-1 was significantly increased in 
response to exogenously applied ZnCl2 (200 µM, Fig. 2.1B and 2.1C). The NO donor, SNAP 
(200 µM) also caused significant nuclear translocation of EGFP-MTF-1 (Fig. 2.1D) though the 
effects were not as pronounced as those for zinc. 
We performed Western blotting on nuclear extracts prepared from SPAEC using rabbit 
polyclonal anti-MTF-1 to confirm that native MTF-1 also responded to NO and found that 2 hr 
D. 
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exposure to either ZnCl2 (200 µM) or SNAP (200 µM) caused increased nuclear localization of 
MTF-1 (Fig. 2.2).  
 
 
Figure 2-2 MTF-1 western blot of nuclear extracts from SPAEC.  MTF-1 was detected using rabbit 
polyclonal anti-MTF-1 (kindly donated by G. Andrews) showing that a 2 hr exposure to either 200 µM ZnCl2 or 200 
µM SNAP caused increased nuclear localization of MTF-2.  Western blotting of whole cell lysates showed that 
neither treatment affected changes in total cellular MTF-1 protein (data not shown). 
 
Neither treatment affected changes in total cellular MTF-1 protein (data not shown).  
2.3.4.2  NO-mediated nuclear translocation of pEGFP-MTF-1 is dependent on 
metallothionein 
We and others have demonstrated NO-mediated increases in labile zinc in several cell 
types [62; 75; 134; 135]. Furthermore, the absence of a response in cells derived from MT null 
mice indicated that MT was the requisite target for NO-induced changes in intracellular zinc 
homeostasis [62; 75]. We transiently transfected pulmonary endothelial cells from MT +/+ and -
/- mice with the EGFP-MTF-1 reporter construct to test the hypothesis that NO-induced 
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activation of MTF-1 was via zinc release from MT. In agreement with the data obtained in 
SPAEC (Fig. 1) MLEC from MT +/+ animals showed a significant increase in the nuclear 
localization of the pEGFP-MTF-1 chimera following 2 h treatment with the NO donor S-nitroso-
N-acetyl penicillamine (SNAP, 200 µM, Fig. 2.3, upper panel).  In contrast, SNAP did not cause 
a nuclear translocation of EGFP-MTF-1 in MLEC that were isolated from MT null mice (Fig. 
2.3, lower panel) demonstrating a central role for MT in mediating these responses.  
 
 
A. 
Figure 2-2 continued on next page 
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Figure 2-3 Wild-type and metallothionein null mouse pulmonary endothelial cells transiently transfected 
with the EGFP-MTF-1 chimera.  In wild-type cells, exposure to both the nitric oxide donor SNAP (200 µM) and 
ZnCl2 (200 µM) caused the fluorescent chimera to migrate to the nucleus of a significant number of the cells 
examines (2.3A, top panel and 2.3B).  In contrast, only exposure to ZnCl2 (200 µM) caused nuclear migration of the 
chimera in metallothionein null cels (2.3A, bottom panel and 2.3B) 
 
2.3.4.3  NO induces MT protein expression. 
MTF-1 binds to metal responsive elements present in the proximal promoter of the MT I 
and MT II genes in response to increases in intracellular zinc [136]. We hypothesized that the 
NO-induced changes in labile zinc would impact upon the activity of MTF-1 and, in this manner, 
affect changes in expression of MT protein. Western blotting showed that MT protein levels 
were increased in response to the NO-donor SNAP (200 µM, Fig. 2.4) and low concentrations of 
B. 
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S-nitroso-L-cysteine ethyl ester (L-SNCEE, Fig. 2.4). The increase in protein expression was 
apparent at 2 h, peaked at 8 h and had returned to baseline levels by 12 h.  
 
 
Figure 2-4 Metallothionein western blotting of SPAEC whole cell extracts exposed to NO donors.  MT 
was detected using mouse monoclonal anti-metallothionein (Clone E9, Dako) showing that a 2 hr exposure to the 
nitric oxide donors SNAP (200 µM) and S-nitroso-cysteine ethyl ester (SNCEE) at low doses caused upregulation of 
metallothionein protein expression.  MT protein expression was also upregulated in the presence of 1 µM CdCl2 
(positive control) and was not affected by decomposed nitric oxide donors. 
2.3.5 Discussion 
It is apparent that S-nitrosation of zinc sulfur clusters is an important component of NO 
signaling and that metallothionein is critical link between NO and intracellular zinc homeostasis 
[62; 75]. The present data demonstrates that the metal responsive transcription factor, MTF-1, is 
one cellular target for the MT-released zinc with a resultant impact upon gene expression.   
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2.3.5.1  Activation of MTF-1 
The metallothionein genes are the best characterized of the target genes for MTF-1.  
Heavy metal exposure [64], reactive oxygen species [136] and hypoxia [137] have all been 
shown induce MT gene transcription through activation of MTF-1. While the mechanisms of 
activation are only partially understood, recent evidence [74; 138; 139] supports the hypothesis 
that metals and oxidants activate MTF-1 by causing a redistribution of zinc in the cell [67; 72]. 
MTF-1 is regulated by micromolar concentrations of zinc [140], and itself may function as a 
sensor of cytoplasmic zinc via a subset of zinc fingers with lower binding affinities for the metal 
[67; 141; 142]. Zinc binding would lead to an allosteric change in MTF-1 causing exposure of 
zinc fingers involved in DNA binding [67]. In support of this model, zinc fingers 1, 5 and 6 
appear to play an essential role in metal-induced recruitment of MTF-1 to the MT-1 promoter 
and formation of a stable MTF-1-chromatin complex [143].  
We have shown that: 1) NO increases labile zinc in pulmonary endothelial cells [62]; and 
2) causes increases in the nuclear localization of MTF-1 (Figs. 2.1-2.3). The absence of these 
NO-induced effects on zinc homeostasis and MTF-1 localization in cells derived from MT-null 
mice revealed that MT was central to both processes. Recent data obtained using a cell-free, 
MTF-1-dependent transcription system [74], supported the hypothesis that metallothionein is 
critical to the modulation of MTF-1 activity. Cadmium, copper or hydrogen peroxide induced 
transcription only in the presence of zinc-saturated MT. Furthermore, the apo-protein, thionein, 
inhibited the activation of MTF-1, presumably by sequestering zinc. Our data suggests that the 
mechanism of MTF-1 activation by metals released from MT is also relevant in vivo.   
The nuclear localization of MTF-1 appears to be essential, but not necessarily sufficient, 
for the transcriptional activation in response to zinc [133]. It is increasingly apparent that 
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phosphorylation via multiple kinases including protein kinase C (PKC), c-Jun N-terminal kinase 
(JNK) and tyrosine kinase, is involved in the metal-dependent transactivation of MTF-1 [144; 
145; 146].  Multiple MAP kinase signaling pathways, including JNK have also been implicated 
in the cellular responses to NO related species [147; 148] via S-nitrosation of critical cysteine 
residues [149].  While these reports suggest that NO could directly affect the phosphorylation of 
MTF-1, this is not sufficient to induce translocation of MTF-1 in MT-null cells.   
2.3.5.2  Induction of MT by NO 
NOS-derived NO and NO donors were both recently shown to increase MT mRNA 
expression in bovine aortic endothelial cells [75]. In support of these findings our data confirms 
that MT protein is increased in response to NO and provides the first direct evidence for an effect 
of NO on MTF-1.  Furthermore, physiologically relevant increases in NO have been shown to 
induce glutathione (GSH) synthesis in vascular endothelial cells, in part through increased 
expression of gamma-glutamylcysteine synthase (γGCS) (78). MTF-1 is a crucial transcriptional 
regulator for basal expression of γGCS [70] and while the response was independent of cGMP 
[150; 151], the mediators involved in the NO-dependent signaling for γGCS remain unclear. 
Conversely, iNOS inhibition decreased MT I and MT II in brain and liver [152]. It is not clear 
whether the discrepant results are tissue specific, are due to non-specific effects of the inhibitor, 
or reflect concentration dependent effects of NO on transcriptional activation.  
2.3.5.3  Interactions of MTF-1 and NO 
The zinc finger structure is the most prevalent DNA binding motif of transcription factors 
[153]. NO has been shown to disrupt the zinc fingers of LAC9 [59], Sp1 and EGR-1 [134] 
causing reversible inactivation of gene transcription. In contrast to the zinc clusters of MT, the 
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zinc fingers of MTF-1 do not appear to be targets for NO, in that disruption of the zinc thiolate 
bonds would actually be expected to weaken the DNA binding affinity of MTF-1 [67]. In 
contrast, we observed an activation of MTF-1 in response to NO, as evidenced by the increase in 
nuclear localization of MTF-1 and induction of MT protein. Such specificity of targets has been 
predicted to be secondary to thiol nucleophilicity (e.g. pKa) and has been reported to be affected 
by allosteric factors, hydrophobicity, subcellular localization and complex aspects of the three 
dimensional structure of the protein [91]. 
2.3.5.4  Perspective 
NO may either promote or inhibit apoptosis [154; 155].  In general, if a cell is depleted of 
GSH and is undergoing oxidative stress, then exposure to large amounts of NO invariably leads 
to cell death.  In contrast, in a cell with a more favorable redox status, low doses of NO tend to 
be anti-apoptotic. This phenomenon was originally noted in cultured endothelial cells that 
became resistant to LPS-induced apoptosis when synthesizing NO after direct gene transfer of 
human inducible nitric oxide synthase (iNOS) [23; 156].   
We previously reported that S-nitrosation of Zn thiolate clusters in MT is a critical 
component of cellular redox sensitivity linking NO to Zn homeostasis in pulmonary endothelial 
cells [61; 62]. We now show that the resultant NO-induced changes in labile zinc impact upon 
the activity of the Zn-sensitive transcription factor MTF-1.  While the physiological implications 
of this novel pathway have yet to be identified, NO-induced activation of MTF-1 and increased 
expression of protective genes may contribute to the observed anti-apoptotic effects of NO and 
protection from oxidative stress.  
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3.0  CHAPTER 3:  DETECTION OF S-NITROSOTHIOLS IN PULMONARY 
ENDOTHELIAL CELLS 
In Preparation 
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Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206 
3.1 INTRODUCTION 
We expanded upon our study of NO-mediated gene regulation by examining the implications of 
S-nitrosation as an emerging cyclic GMP-independent, post-translational NO modification that 
may form a unique signaling pathway [81; 91; 93; 157; 158; 159].  We used a fluorescent 
modification of the biotin switch technique [77; 116] in combination with proteomic techniques 
to examine the S-nitrosation status of metallothionein in sheep pulmonary artery endothelial cells 
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exposed to the NO-donor L-S-nitrosocysteine ethyl ester (L-SNCEE).  Previous work in our 
laboratory had suggested that the effect of NO on zinc homeostasis in endothelial cells might be 
dependent upon S-nitrosation of the cysteine residues in metallothionein [60; 61; 62].  We 
examined this hypothesis in greater detail using our modified biotin switch technique and were 
able to demonstrate that metallothionein is in fact nitrosated in sheep pulmonary artery 
endothelial cells. 
We then expanded our study of S-nitrosation in endothelial cells to include five types of 
cultured endothelial cells isolated from four different species; human, mouse, rat and sheep.  
Using our fluorescent S-nitrosothiol detection technique in combination with proteomic analyses 
we were able to identify potential protein targets of S-nitrosation from several categories of 
cellular proteins including cytoskeletal, chaperone, and glycolytic proteins.  We also examined 
the effect of increased intracellular nitric oxide production via an adenoviral vector encoding the 
cDNA for human iNOS.   
 
3.2 MANUSCRIPT AS PREPARED FOR SUBMISSION  
3.2.1 Abstract 
 S-nitrosation is emerging as a potentially important post-translational signaling 
pathway.  To study nitric oxide-mediated S-nitrosation in endothelial cells we modified the S-
nitrosoprotein detection method known as the biotin switch to allow us to fluorescently tag and 
detect S-nitrosated proteins directly using two dimensional gel electrophoresis and mass peptide 
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fingerprinting. We used the fluorescent modification of the biotin switch assay to identify S-
nitrosated metallothionein in endothelial cells.  In addition we analyzed S-nitrosation of the 
proteome in human, mouse, rat, and sheep endothelial cells exposed to both exogenous and 
endogenous nitric oxide.  We identified several novel targets of S-nitrosation in endothelial cells 
including members of the protein disulfide isomerase family, heat shock organizing protein 1, 
and aldolase A. We have developed a fluorescence-based proteomic screening method to identify 
S-nitrosoproteins in endothelial cells, which will allow us to continue to study nitric oxide-
mediated signaling pathways in endothelial cells.    
3.2.2 Keywords 
S-nitrosation 
Nitric Oxide 
Endothelium 
Endothelial Cells 
S-nitrosoalbumin 
S-nitrosylation 
Biotin Switch 
3.2.3 Introduction 
Nitric oxide (NO) is an important modulator of cellular function.  It is a small, easily 
diffusible molecule known to affect many cellular functions including smooth muscle cell 
relaxation in the vasculature, and neurotransmission. It also contributes to the defense 
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mechanisms of the immune system. NO is a reactive molecule due to its paramagnetic nature.  It 
can react with cellular metals to form metal-nitrosyl compounds, with oxygen to form nitrite and 
nitrate, with superoxide to form peroxynitrite, and with cellular nucleophiles [34].  Most of the 
focus on NO-mediated signaling involves the metal dependent activation of the cyclic guanosine 
monophosphate (cGMP) signaling pathway.   In this pathway NO binds to the active site heme of 
guanylyl cyclase and leads to an increase in formation of cGMP [160].  However, in recent 
studies a new, cGMP-independent signaling pathway involving nitrosation of protein thiols has 
emerged. 
Thiols are among the most numerous cellular nucleophiles and recent studies have 
demonstrated that S-nitrosothiols may play an important role in cellular signaling [81; 159; 161].  
In this study we have focused on a particular aspect of NO’s interaction with cellular thiols, 
namely S-nitrosation.  S-nitrosation reactions involve an attack by a nucleophilic thiol group on a 
nitrosonium (NO+) equivalent [161].  In the cellular milieu, certain molecular species can be 
thought of as “carriers” of nitrosonium, including metal-nitrosyls, nitrite and peroxynitrite, and 
perhaps most importantly, other S-nitrosothiols [93].  Transfer of nitrosonium equivalents 
between an existing S-nitrosothiol and the target thiol is referred to as transnitrosation [161]. 
Emerging evidence has demonstrated that S-nitrosation of proteins can affect their 
function, and in some cases their sub-cellular distribution.  In most cases this phenomenon can 
be traced to post-translational modification of a specific cysteine thiol or thiols in the protein 
[159].  In addition, it has been postulated that there are enzymes that may remove this NO-based 
modification in a specific manner [84; 162; 163].  When all of the studies are considered, S-
nitrosation seems to be an emerging post-translational signaling mechanism somewhat analogous 
to protein phosphorylation.   
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In addition, dysregulation of or changes to S-nitrosative signaling in cells has been linked 
to a number of diseases. Decreased levels of S-nitrosothiols have been found in the airway lining 
fluid in asthma while S-nitrosothiol levels are elevated in the synovial fluid of the joints in 
arthritis [30].  Studies have also identified increases in S-nitrosoalbumin in plasma from patients 
with pre-eclampsia [164; 165].  Finally, elevated levels of S-nitrosohemoglobin have been found 
in patients suffering from pulmonary hypertension [30].  When combined with the emerging 
evidence for NO participation in specific signaling pathways, these links to disease highlight the 
importance of further study of S-nitrosothiol based signaling events in cells. 
Detecting S-nitrosothiols in biological systems can be difficult.  There are a variety of 
measurement systems including chemical and flash-photolysis that can be used in conjunction 
with a chemiluminescent detection techniques [107].  However, chemical detection systems can 
produce artifacts when used to study complex systems such as whole cell lysates since other 
forms of NO are detected in addition to S-nitrosothiols.  Flash-photolysis chemiluminescence is a 
very sensitive technique, but it is generally used to detect either total S-nitrosothiols in a sample, 
or the S-nitrosation of a particular, purified protein.  This technique does not lend itself easily for 
use in proteomic methods.  Recently, Jaffrey and his colleagues have developed a technique to 
identify S-nitrosothiols in whole cell lysates known as the biotin-switch method [77; 116].    The 
original version of this method replaces the NO moiety of the S-nitrosothiol with a biotin moiety 
(N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio)propionamide–biotin-HPDP) that can be detected 
on an immunoblot using an anti-biotin antibody or an appropriately labeled streptavidin 
molecule.  We have modified this method to allow it to be used more efficiently in proteomic 
techniques.  We increased the number of free thiol blocking steps to reduce background and 
increased the ascorbate concentration and incubation time to increase sensitivity in S-nitrosothiol 
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detection.  In addition we have replaced the biotin moiety with a fluorescent label in order to 
allow S-nitrosated proteins to be detected directly using two-dimensional gel electrophoresis. 
Using our modified method, we examined the S-nitrosation of the proteome in 
endothelial cells from several species (human, rat, sheep and mouse) in the presence and absence 
of both exogenous (L-SNCEE and S-nitrosoalbumin) and endogenous (an adenoviral vector 
expressing iNOS) NO donors. 
3.2.4 Materials and Methods 
3.2.4.1 Materials 
AdiNOS was a gift from Tim Billiar at the University of Pittsburgh.  Cell culture media 
and supplements were obtained from Invitrogen except where noted in the text.  Heparin, 
HEPES, EDTA, neocuproine, MMTS, CHAPS, trifluoroacetic acid and ammonium bicarbonate 
were obtained from Sigma.  Two-dimensional gel electrophoresis (2DGE) grade urea was 
obtained from Invitrogen.  Ascorbate was obtained from Aldrich, while acetonitrile was from 
Pierce and α-cyano-4-hydroxycinnamic acid was from Fluka. 
3.2.4.2  Cell culture and isolation 
 
Human Pulmonary Artery Endothelial Cells (HPAEC) were a gift from Aaron 
Barchowsky (University of Pittsburgh).  Rat Pulmonary Artery Endothelial Cells (RPAEC) were 
a gift from Troy Stevens (University of Alabama, Birmingham).  Rat microvascular endothelial 
cells were purchased from VEC Technologies, Renssalaer, NY.    RPAEC were cultured in 
Dulbeccos’ Modified Eagle Medium (DMEM) with 10% FBS, 100 U/mL penicillin, and 100 
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µg/mL streptomycin at 37°C in an atmosphere of 5% CO2.  RMVEC were cultured in flasks 
precoated with sterile 1% gelatin in Hank’s Buffered Saline Solution (HBSS, Invitrogen) in 
MCDB-31 complete medium (VEC Technologies) containing DMEM supplemented with 5% 
FBS, endothelial cell growth factor, heparin, 50 U/mL penicillin, and 50 µg/mL streptomycin at 
37°C in an atmosphere of 5% CO2.  Sheep Pulmonary Artery Endothelial Cells (SPAEC) were 
cultured from sheep pulmonary arteries obtained from a local slaughterhouse as previously 
described [128] and grown in OptiMEM (Invitrogen) with 10% fetal bovine serum, 100 U/mL 
penicillin, and 100 µg/mL streptomycin at 37°C in an atmosphere with 5% CO2.  Mouse lung 
endothelial cells were isolated by modifications of a previous protocol [25].  Briefly, mouse 
lungs were perfused and rinsed with a solution of HBSS with calcium and magnesium and 
10U/mL heparin.  Lungs were minced and digested with collagenase (Type I Sigma, 100 µg/mL 
in HBSS with calcium and magnesium) for 25 minutes with occasional agitation.  The resulting 
digest was filtered 2X through 100 µm cell strainers and 1X through 75 µm cell strainer and 
centrifuged (800 rpm, 8 minutes, 4°C) to pellet cells.  Cells were incubated in 1X binding buffer 
(1.5 mM NaH2PO4, 5 mM Na2HPO4, 140 mM NaCl, 0.2 mM EDTA, 0.5% BSA) with sheep 
anti-rat Dynabeads (Invitrogen) that had been coated overnight with a rat anti-mouse monoclonal 
antibody to platelet endothelial cell adhesion molecule-1 (PECAM-1, BD Biosciences) according 
to manufacturer’s instructions for 1 hour at 4°C with constant agitation.  Cells were purified 
magnetically according to manufacturer’s instruction (Dynal, Invitrogen) by rinsing 5 times in 
cell culture medium using the appropriate magnet for isolation.  After washes, cells attached to 
beads were plated in 0.1 mg/mLcollagen/0.1% gelatin (both from Sigma) coated culture plates in 
MLEC medium [OptiMEM (Invitrogen), with 10% FBS, 100 U/mL penicillin, 100 µg/mL 
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streptomycin, EndoGro (VEC Technologies), 2 mM L-glutamine, 1X non-essential amino acids 
(Invitrogen), 55 µM β-mercaptoethanol, and 10 U/mL heparin) in an atmosphere with 5% CO2. 
3.2.4.3   Synthesis of S-nitrosoalbumin 
 
S-nitrosoalbumin was synthesized and characterized as previously described [83]. 
3.2.4.4  Treatment and harvest of endothelial cells for S-nitrosothiol detection 
 
L-SNCEE was synthesized immediately before use as previously described [127].  
Endothelial cells were exposed to 100 µM L-SNCEE in full growth media at 37°C for 30 
minutes.  Endothelial cells were exposed to S-nitrosoalbumin in HBSS with calcium and 
magnesium at 37°C for 30 minutes.  Cells were harvested immediately by trypsinizing and cell 
pellets were washed 1X in HBSS before being resuspended in HEN buffer.  Cells were sonicated 
(6 X 1 second pulses at 50% maximum input, Sonics and Materials Vibracell VC-30) and lysates 
were cleared by centrifugation at 10,000 x g at 4°C for 10 minutes.  Protein concentration was 
measured using the Bio Rad Protein Assay and supernatants were stored at -80°C until used in 
the S-nitrosoprotein detection assay. 
3.2.4.5   Metallothionein western blot 
 
SPAEC were infected with a 500:1 multiplicity of infection (MOI) of AdMT and whole 
cell lysates were harvested at 24 hours post-infection by trypsinizing and sonicating cells (6 X 1 
second pulses at 50% maximum input, Sonics and Materials Vibracell VC-30) in HEN buffer 
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(see composition below).  Samples were processed for S-nitrosothiol detection as below and 2D 
gel electrophoresis was performed as below using pH 3-10NL ZOOM strips (Invitrogen) and 4-
20% Tris-Glycine ZOOM IPGRunner gels.  Samples were transferred to nitrocellulose 
membrane, the membrane was fixed in 2% glutaraldehyde for 5 minutes at 4°C, and MT was 
detected using a primary mouse anti-horse MT antibody (Clone E3, Dako) and a rat anti-mouse 
Alexa 488 secondary antibody (Invitrogen) [166].  Fluorescent images of membranes were 
obtained using a Typhoon imaging system (GE Lifesciences).   
3.2.4.6   Detection of S-nitrosothiols and two-dimensional gel electrophoresis 
 
S-nitrosothiols were detected in cellular lysates using the biotin-switch method with the 
following modifications [77; 116].  Protein samples were resuspended at a concentration of 0.8 
µg/µL in 100 uL total volume HEN buffer (250 mM HEPES, pH 8.0, 1 mM EDTA, 0.1 mM 
neocuproine).  Proteins were incubated with four volumes of MMTS blocking buffer (HEN 
buffer with 2.5% SDS and 20 mM MMTS) at 50°C in the dark for twenty minutes with frequent 
vortexing.  Protein was precipitated by addition of two volumes of ice-cold acetone and 
incubation at -20°C for 20 minutes followed by centrifugation at 12,000 x g at 4°C for 15 
minutes.  Precipitated protein was washed with ice-cold acetone and centrifuged at 12,000 x g at 
4°C for 5 minutes.  Protein was then resuspended in 100 µL HEN buffer and MMTS blocking 
was repeated as described above.  After the second round of blocking, protein was precipitated 
and washed as described above.  Each sample was resuspended in HENS buffer (HEN buffer, pH 
8.0 adjusted to 1% SDS) and ascorbate was added to a final concentration of 30 mM.  Alexa-547 
labeled maleimide (Invitrogen) was added to each sample to a final concentration of 2 mM and 
samples were incubated at room temperature in the dark for two hours with gentle rocking.  The 
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labeling reaction was stopped by running each sample through the Plus One 2D Gel Sample 
Clean Up Kit according to manufacturer’s instructions (GE Lifesciences).  Samples were 
resuspended in 1X IEF sample buffer (8M urea, 2% CHAPS, 0.002% bromophenol blue), 
applied to ZOOM IPGRunner IEF strips (Invitrogen), and strips were allowed to hydrate 
overnight.  ZOOM IPGRunner IEF strips were focused according to manufacturer’s suggestions 
(ZOOM IPGRunner, Invitrogen) and were run on 4-20% Tris-Glycine ZOOM Gels (Invitrogen) 
for second dimension.  Fluorescent images of S-nitrosated proteins were obtained using a 
Typhoon imaging system (GE Lifesciences) and gels were stained with colloidal Coomassie blue 
for 18 hours (BioRad Bio-Safe).  Protein spots of interest were picked from coomassie stained 
gels and prepared for mass peptide fingerprinting. 
3.2.4.7   Preparation of proteins and mass peptide fingerprinting 
 
Gel pieces containing proteins of interest were prepared for peptide mass fingerprinting 
as previously described [167].  Briefly, gel pieces were dehydrated at room temperature for 15 
minutes in 2 x 100µL washes in 50% methanol/25 mM NH4HCO3.  This step was followed by a 
15 minute room temperature wash in 50% acetonitrile/ 25 mM NH4HCO3 (100 µL per sample).  
Gel pieces were incubated in 50 µL 100% Acetonitrile for 5 minutes at room temperature and 
then dried to completion at 65°C.  Trypsin digestion was performed using 10 µL of 20 ng/µL 
trypsin (Promega Trypsin Gold) in 25 mM NH4HCO3 at 37°C for 18 hours.  Digests were 
removed to a new tube, and peptides were eluted with 30 µL 1% trifluoroacetic acid (15 minutes 
at room temperature) followed by an elution step with 30 µL 50% acetonitrile/ 1% trifluoroacetic 
acid (15 minutes at room temperature).  Supernatants containing peptides were evaporated to 
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dryness in a SpeedVac at room temperature.  The dried peptides were resuspended in 50% 
acetonitrile/ 0.3% trifluoroacetic acid and mixed with an equal volume of saturated α-cyano-4-
hydroxycinnamic acid.  Duplicate 0.75 µL aliquots were spotted on a 192-well matrix-assisted 
laser desorption ionization (MALDI) plate (Applied Biosystems).  MALDI-time of flight 
(MALDI-TOF) and MALDI-TOF-TOF analyses were performed using an ABI 4700 mass 
spectrometer at the University of Pittsburgh Integrated Genomics and Proteomics Core Facility.  
MALDI-TOF analysis was performed in the reflectron mode.  Peak lists were analyzed using an 
in house version of Mascot (Matrix Science). 
3.2.4.8   Infection of sheep pulmonary artery endothelial cells with AdiNOS and 
measurement of nitric oxide production 
 
SPAEC were infected with a 1000:1 MOI of an adenovirus encoding inducible nitric 
oxide synthase (AdiNOS).  Uninfected and infected SPAEC (SPAEC and SPAEC.iNOS 
respectively) were cultured in the presence and absence of the nitric oxide synthase inhibitor L-
NAME (1 mM) for 72 hours post-infection.  Nitrate accumulation in the culture supernatant was 
measured using the Greiss reaction, as previously described [168; 169].  Absorbance was 
measured at 550 nm, and nitrite was quantified using NaNO2 as a standard. 
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3.2.5 Results 
3.2.5.1   Detection of S-nitrosated metallothionein 
Previous evidence from our laboratory and others indicates that the low molecular weight 
zinc-binding protein metallothionein (MT) may play a role in NO-mediated signaling [60; 61; 
62].  Previous studies in our laboratory demonstrated that exposure of a fluorescence resonance 
energy transfer based-MT reporter to either endogenous or exogenous NO resulted in release of 
zinc, presumably via S-nitrosation its cysteine thiols [60; 61].   We decided to use the S-
nitrosation assay that we developed to examine the S-nitrosation state of MT in SPAEC.  We 
used an adenoviral vector expressing the cDNA for human metallothionein IIa (AdMT) in order 
to increase expression of MT in SPAEC in hopes of being able to reach a level that would allow 
protein identification via MS analysis.  We first labeled the S-nitrosoproteins present in SPAEC 
lysates using our S-nitrosoprotein detection protocol.  Labeled samples were used in 2DGE in 
combination with western blotting for MT in order to determine whether MT is nitrosated in 
SPAEC (Figure 3.1).  
In the overlay of the fluorescently labeled S-nitrosoproteins (Figure 3.1A; in red) and the 
MT immunoblot using a fluorescently labeled secondary antibody (Figure 3.1A; in green) it 
appears that MT is in fact S-nitrosated in SPAEC.  This becomes more apparent when the S-
nitrosoproteins and MT immunoblot are viewed in separate images (Figure 3.1B and C, 
respectively).  Protein spots were picked from the same location on a gel run under identical 
conditions and stained with Coomassie for MS protein identification (Figure 3.1D).  
Unfortunately, the protein concentration was not high enough in the gel pieces to positively 
identify MT.  However the primary antibody used in this study is highly specific for MT [166].  
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This leads us to believe that MT is S-nitrosated in SPAEC based upon the results of the S-
nitrosoprotein detection assay performed in tandem with a MT immunoblot. 
 
Figure 3-1 Detection of S-nitrosated metallothionein by S-nitrosation assay in combination with 
immunoblotting.  SPAEC were infected with an adenovirus expressing the cDNA for human metallothionein IIa and 
cell lysates were harvested 24 hours post-infection.  S-nitrosated proteins were labeled using an Alexa-647 
maleimide in the S-nitrosoprotein detection assay (red).  Metallothionein (MT) was detected using a primary anti-
mouse antibody against MT and an Alexa-488 labeled secondary antibody (green).  A) Overlaid image of both 
Alexa-647 labeled S-nitrosated protein and Alexa-488 labeled secondary antibody indicating the location of MT on 
membrane (arrow).  B)  Alexa-488 channel of image indication location of MT on membrane (arrow).  C)  Alexa-
647 channel of image indicating presence of S-nitrosated proteins on membrane.  S-nitrosated protein is present in 
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the same area where MT was detected (arrow).  D) Coomassie stained gel image used to pick spots (from region 
indicated with arrow) for MS identification of MT. 
 
3.2.5.2 S-nitrosation in rat pulmonary artery endothelial cells 
 
We examined the formation of S-nitrosated proteins in rat pulmonary artery endothelial 
cells (RPAEC) exposed to two different NO donors.  The first, L-SNCEE is a cell-permeant 
nitrosating agent [127].  The second, S-nitrosoalbumin, is a nitrosating agent that can participate 
in trans-nitrosation reactions [42; 83; 170; 171].  We exposed RPAEC to both donors and then 
used our modification of the biotin-switch assay in combination with two-dimensional 
electrophoresis and mass spectrometry to identify S-nitrosoproteins (Figure 3.2; Table 3.1 and 
3.2).   
In order to maximize resolution in our experiments we chose to use a miniature two-
dimensional gel electrophoresis (2DGE) format (ZOOM IPGRunner, Invitrogen).  The small size 
of the gels allowed us to ensure detection of S-nitrosated proteins given the relatively small 
amounts of protein harvested from cultured endothelial cells (in the µg range vs. the mg range 
necessary to use traditional large format [2DGE]) [172].  In order to verify consistency between 
gel runs using the miniature gel format, the experiment with RPAEC was repeated in triplicate.  
The gels shown are representative of each individual experiment, while the proteins identified 
are a compilation of positive identifications from all experiments (Figure 3.2; Table 3.1 and 3.2). 
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Figure 3-2 S-nitrosothiol detection in rat pulmonary artery endothelial cells (RPAEC).  RPAEC were 
exposed to NO donor for 30 minutes as described in materials and methods.  Cell lysates were used in the S-
nitrosothiol detection assay in combination with 2DGE.  Numbered spots represent S-nitrosated proteins identified 
by MS analysis.  Numbers coordinate with Gel Position category in Tables 3.1 and 3.2  A) Untreated RPAEC; B) 
RPAEC exposed to 200 µM S-nitrosoalbumin; C) RPAEC exposed to 100 µM L-SNCEE 
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Table 3-1 Proteins not previously known to be S-nitrosated as identified by MS analysis.  S-nitrosated 
proteins identified in RPAEC.  Gel position identifiers indicate protein position on gels in Figure 3.1. 
 
Gel Position Protein MW PI Conditions Accession 
Number 
Function 
B16; C37 ERp60 protein (PDI-like) 63.0 6.4 SNO-Albumin 
and SNCEE 
gi|3688521 Chaperone 
B29 Expressed in non-metastatic 
cells 2 
17.3 6.92 SNO-Albumin gi|55778652 Signaling 
B25 Thiol-specific antioxidant 
protein 
24.8 5.64 SNO-Albumin gi|3688521 Cytoprotective 
C38 HOP1 63.0 6.40 SNCEE     gi|38181876 Chaperone 
C44 Ribosomal protein large P2 17.1 4.46 SNCEE gi|71795613 Protein 
synthesis 
A2; B15; 
C32 
Heat shock protein 8 7.1 5.37 All gi|31981690 Chaperone 
A6; B20; 
C35; C36 
PDI associated 3 57.0 5.88 All gi|38382858 Chaperone 
A12; B27 B-galactoside-binding lectin 15.1 5.14 All gi|9845261 Cytoskeleton 
A11; B26 Non-muscle myosin alkali 
light chain 
17.1 4.46 All gi|998520 Cytoskeleton 
A13; B30 Profilin 15.1 8.46 All gi|1628436 Cytoskeleton 
C39 Reticulocalbin 37.9 4.72 All gi|53734248 ER Protein 
A7; B23; 
C43 
Aldolase A 39.6 8.31 All gi|202837 Glycolysis 
A10 Phoshopglycerate mutase 1 28.9 6.67 All gi|76779285 Glycolysis 
A4; B18; 
C34 
Mixture of Iodothyronine 5’ 
monodeiodinase 
And 
Prolyl 4-hydoroxylase 
54.3 
 
 
57.2 
4.87 
 
 
4.82 
All       gi|202549 
 
     gi|38197382 
 
 
Hormone 
Synthesis 
 
Collagen 
Synthesis 
B22; C42 Serpin H1 46.6 8.88 All gi|55824765 Signaling 
 
 
 
 
 
 
 
   
 52 
Table 3-2 Proteins known to be targets for s-nitrosation as identified by MS analysis in this study.  S-
nitrosated proteins that have previously been identified as targets of S-nitrosation in other studies as identified in 
RPAEC exposed to NO donors are represented in the table.  Asterisks indicate proteins identified as targets of S-
nitrosation in previous studies in endothelial cells. 
 
 
Gel 
Position 
Protein MW PI Conditions Accession 
Number 
Function Known S-NO 
Modified 
A1; B14; 
C31 
Heat shock 
protein 70 
72.4 5.07 All gi|38303969 Chaperone Yes [173; 174] 
A5; B19 Vimentin 53.7 5.06 All gi|57480 Cytoskeleton *Yes [175] 
C40; 
C41 
Gamma actin 59.0 5.67 All gi|109492380 Cytoskeleton *Yes [77; 159; 176] 
A3; B17; 
C33 
Calreticulin 48.1 4.33 All gi|38565977 Chaperone Yes [173] 
A9; B24 GAPDH 36.0 7.63 All gi|56611127 Glycolysis *Yes [77; 159; 175; 
176; 177; 178] 
B28 Eukaryotic 
translation 
initiation factor 
5A2 
17.1 5.38 All gi|76827038 Protein 
Synthesis 
Yes [92; 179] 
A8 hnRNP A/B 36.3 6.49 All gi|13786156 RNA 
Processing 
Yes [177; 180] 
 
 
Since cultured endothelial cells produce NO under basal conditions, a relatively large 
population of S-nitrosated proteins can be detected.  In accordance with the established lack of 
gel-to-gel variability in 2DGE [172], we were able to identify a population of proteins that are S-
nitrosated regardless of the treatment condition (Figure 3.2).  In addition we were able to identify 
several proteins that appeared to be newly nitrosated upon exposure to NO donor (Figure 3.2).  
It is of note that even large doses of NO donors (100 µM SNCEE and 200 µM S-NO 
Albumin) did not result in large changes in the overall S-nitrosation profile of RPAEC.  
However, we identified both proteins that have not been previously recognized to be S-nitrosated 
in general (Table 3.1) and proteins that had been identified in other studies of S-nitrosation 
(Table 3.2). 
   
 53 
3.2.5.3   Detection of S-nitrosated proteins in endothelial cells from multiple species 
 
In addition to RPAEC, we exposed human aortic endothelial cells (HAEC), mouse lung 
endothelial cells (MLEC), rat microvascular endothelial cells (RMEC), and sheep pulmonary 
artery endothelial cells (SPAEC) to NO donors and identified S-nitrosated proteins.  We were 
able to detect S-nitrosated proteins that are involved in a variety of cellular processes (Figure 
3.3). 
 
Figure 3-3 Categories of S-nitrosoproteins identified in all species of endothelial cells studied.  S-
nitrosoproteins identified in human, mouse, rat, and sheep endothelial cells are represented according to protein 
function. 
 
It is interesting to note that two major groups of modified proteins emerged in this study, 
chaperone and cytoskeletal proteins.  In this respect our study agrees with previous studies that 
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identified members of these same groups of proteins as being S-nitrosated.  As in the studies in 
RPAEC we were able to identify both proteins that have not been previously recognized targets 
of S-nitrosation in endothelial cells (Table 3.3) as well as proteins that had been identified in 
previous studies of S-nitrosation (Table 3.4), some of which were performed using cultured 
endothelial cells. 
Table 3-3 Proteins not previously known to be S-nitrosated as identified by MS analysis in human, mouse, 
rat, and sheep endothelial cells.  Abbreviations:  HA=human aortic endothelial cells; M=mouse lung endothelial 
cells; RM=rat microvascular endothelial cells; S=sheep pulmonary artery endothelial cells 
 
Protein MW PI Species Conditions Accession 
Number 
Function 
Endo PDI (Thioredoxin domain containing 
protein 5 isoform 2 
44.4 5.77 HA SNCEE gi|42794775 Chaperone 
HOP1 63.0 6.40 HA SNCEE gi|38181876 Chaperone 
Heat shock protein 47 – non-inhibitory serpin 46.6 8.9 RM Baseline gi|51450 Chaperone 
Heat shock protein 1 58.0 5.35 RM All gi|133428 Chaperone 
Aldolase A 39.6 8.31 S All gi|202837 Glycolysis 
hnRNP A2/B1/B0 37.4 9.0 S All  RNA 
processing 
hnRNP A3 37.2 8.5 S, M All  RNA 
processing 
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Table 3-4 Proteins known to be targets for S-nitrosation as identified by MS analysis in human, mouse, rat, 
and sheep endothelial cells.  Asterisks indicate proteins identified as targets of S-nitrosation in previous endothelial 
cell studies.  1=Result in human aortic endothelial cells 2=Result in mouse lung endothelial cells  Abbreviations”  
HA=human aortic endothelial cells; M=mouse lung endothelial cells; RM=rat microvascular endothelial cells; 
S=sheep pulmonary artery endothelial cells 
 
Protein MW PI Species Conditions Accession 
Number 
Function Known S-NO 
Modified 
B-tubulin 50.3 4.79 RM SNO-Albumin gi|62078507 Cytoskeleton Yes [77; 159] 
Heat shock 
protein 60 
61/3 5.70 HA SNCEE gi|77702086 Chaperone Yes [177] 
Enolase 1 47.5 7.01 HA SNCEE       gi|4503571 Glycolysis Yes [173; 177] 
Heat shock 
protein 70 
72.4 5.07 HA, M, 
RM 
All, SNCEE1      gi|38303969 Chaperone Yes [173; 179]  
Vimentin 53.7 5.06 HA, M, 
RM, S 
All, SNCEE1 gi|57480 Cytoskeleton *Yes [175] 
Gamma actin 59.0 5.67 M All, PI Shift 
with SNCEE2 
gi|109492380 Cytoskeleton *Yes [77; 159; 
176] 
Peroxiredoxin 1 22.3 8.27 RM All gi|56789700 Cytoprotective *Yes [175; 176; 
179; 181] 
B-actin   RM All  gi|4501885 Cytoskeleton *Yes [77; 159; 
175; 176; 177] 
hnRNP A/B 36.3 6.49 RM All gi|13786156 RNA processing Yes [177; 180] 
Albumin 71.0 5.8 S All gi|162648 Transport/Storage Yes [159] 
 
 
In both our studies of RPAEC and other endothelial cell species, some of the targets of S-
nitrosation remain the same regardless of species as evidenced by their identification in multiple 
species. 
3.2.5.4   S-nitrosoprotein profile of sheep pulmonary artery endothelial cells exposed to an 
endogenous source of nitric oxide 
 
In order to examine the effects of a more physiologically relevant source of NO we 
infected SPAEC with an adenovirus expressing the human cDNA for inducible nitric oxide 
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synthase (AdiNOS; SPAEC.iNOS).  Uninfected SPAEC (SPAEC) and SPAEC.iNOS were 
cultured for 72 hours post-infection either in the presence or absence of the NO inhibitor L-
NAME.  Uninfected SPAEC were capable of producing NO under our cell culture conditions, 
and this NO production was enhanced upon infection with AdiNOS (SPAEC.iNOS; Figure 3.4).  
In both SPAEC and SPAEC.iNOS, culture in the presence of L-NAME resulted in decreased, but 
still detectable, NO production (Figure 3.4).   
 
Figure 3-4 Nitric oxide production in sheep pulmonary artery endothelial cells.  Nitric oxide production in 
uninfected sheep pulmonary artery endothelial cells (SPAEC) and sheep pulmonary artery endothelial cells infected 
with a 1000:1 MOI of AdiNOS (SPAEC.iNOS) was measured as nitrite in the medium using the Greiss Assay.  
SPAEC and SPAEC.iNOS were cultured in the presence and absence of 1 mM L-NAME, a nitric oxide synthase 
inhibitor. 
 
Upon 2DGE analysis of S-nitrosated proteins from SPAEC and SPAEC.iNOS cultured 
with and without L-NAME we observed several phenomena.  First, as in our previous studies 
with various types of endothelial cells, we observed a set of proteins that are S-nitrosated in 
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endothelial cells under basal conditions (Figure 3.5).  In cells exposed to L-NAME there are no 
appreciable differences in the profile of proteins that are S-nitrosated (Figure 3.5).   
 
Figure 3-5 S-nitrosoprotein profile of SPAEC and SPAEC.iNOS.  SPAEC were infected with a 1000:1 
MOI of AdiNOS and protein was harvested 72 hours post-infection.  Protein samples were used in the S-
nitrosoprotein identification assay and 2DGE as described in methods.  A) SPAEC at baseline conditions; B) 
SPAEC.iNOS; C) SPAEC exposed to 1 mM L-NAME for 72-hours; D) SPAEC.iNOS exposed to 1 mM L-NAME 
for 72-hours post-infection. 
 
In addition, although nitric oxide levels were increased in SPAEC.iNOS, there were no 
significant changes in the spectrum of S-nitrosated proteins in these cells, even upon exposure to 
L-NAME (Figure 3.5).  Mass spectrometry analysis of protein spots picked from this series of 
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gels identified both proteins that have not been previously known to be S-nitrosated in 
endothelial cells (Table 3.5) and proteins that have been known to be S-nitrosated in various cell 
types (Table 3.6).   
Table 3-5 Proteins not previously known to be S-nitrosated as identified by MS analysis.  Cell lysates were 
harvested from SPAEC and SPAEC.iNOS 72 hours post-infection and used in the S-nitrosoprotein detection assay. 
 
 
Protein MW PI Conditions Accession Number Function 
Profilin 15.1 8.5 All gi|1127241 Cytoskeleton 
ERp60 (PDI family 63.0 6.4 All gi|1083063 Protein Folding 
 
Table 3-6 Proteins known to be targets for S-nitrosation as identified by MS analysis in this study.  Results 
are for SPAEC and SPAEC.iNOS lysates harvested 72-hours post-infection. 
 
Protein MW PI Conditions Accession 
Number 
Function Known S-NO 
Modified  
Tropomyosin 4 28.6 7.14 All gi|4507651 Cytoskeleton *Yes [176; 178] 
Vimentin 53.7 5.06 All gi|57480 Cytoskeleton *Yes [175] 
GAPDH 36.0 7.63 All gi|56611127 Glycolysis *Yes [77; 159; 175; 
176; 177; 178; 179] 
Aldehyde dehydrogenase 54.9 7.14 All gi|974168 Glycolysis Yes [159] 
Eukaryotic translation 
initiation factor 5A2 
17.1 5.38 All gi|76827038 Protein 
synthesis 
Yes [92; 179] 
 
 
It is interesting to note that in this set of experiments the proteins identified were consistent with 
those identified in our previous experiments with exogenous NO donors in a variety of species of 
endothelial cells (Tables 3.1-3.4).   
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3.2.6 Discussion 
In the present study we add to the growing database of protein targets of S-nitrosation.  In 
particular, our studies in endothelial cells, with their ability to produce endogenous nitric oxide, 
add weight to the growing importance of S-nitrosation as a potential post-translational signaling 
pathway.  Using endothelial cells from a variety of species we were able to identify both 
potential new targets of protein S-nitrosation and known targets of S-nitrosation.  Some of the 
proteins identified in this study have potential connections to nitric oxide.   
Previous studies have identified the actin cytoskeleton as a target for S-nitrosation [182].  
The authors of these studies indicated that actin could be S-nitrosated using GSNO as a NO 
donor and that S-nitrosated actin polymerizes less efficiently than unmodified actin.  It is known 
that the activity of endothelial nitric oxide synthase (eNOS) is partially dependent upon the state 
of the cytoskeleton; particularly in shear stress-mediated NO production [39].  In endothelial 
cells experiencing shear stress actin microfilaments, microtubules and vimentin intermediate 
filaments rearrange.  This disruption of endothelial cell cytoskeletal components, particularly 
actin, results in increased stability of eNOS mRNA [39], perhaps through binding of β-actin 
itself to the mRNA.  Finally, there is evidence that S-nitrosated actin can function as a potent NO 
donor [182]. 
In addition to S-nitrosated actin, we were able to identify other elements of the 
cytoskeleton as potential targets for S-nitrosation.  In particular we identified tropomyosin, a 
protein that has been demonstrated to be one of the most abundant components of the 
cytoskeleton in bovine pulmonary artery endothelial cells [183].  Other studies have 
demonstrated that cell-surface tropomyosin may play a role in preventing angiogenesis through 
its interactions with other extracellular proteins [184]. 
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We were able to identify several isoforms of protein disulfide isomerase (PDI) in our 
studies.  Previous evidence from our laboratory and others demonstrates a link between PDI and 
NO [83; 87; 185].   PDI isoforms are members of the thioredoxin superfamily, and while they 
can be found at the cell surface, they are mainly present in the lumen of the endoplasmic 
reticulum [186].  There are several studies that indicate that PDI is involved in transport of S-
nitrosothiols from the extracellular to the intracellular space [83; 87; 185].  In addition, in this 
study we were able to identify an endothelial cell-specific PDI isoform, EndoPDI, as a target for 
S-nitrosation [187].  Finally, it has been demonstrated that PDI is a subunit of prolyl-hydroxylase 
[188], another protein that we identified as a potential target of S-nitrosation in our study. 
We were also able to identify several proteins that may be involved in linking NO to 
apoptosis in endothelial cells.  It is known that NO has both pro and anti-apototic effects in cells 
depending upon the circumstances [154].  In our studies we were able to identify two proteins 
that other groups have determined to be targets of S-nitrosation in other cell types and that are 
known to be involved in apoptotic pathways involving nitric oxide.   
The first protein that has been identified as a target of S-nitrosation in this study and 
others is eukaryotic translation initiation factor 5A2 (eIF5A2) [92; 179].  eIF5A2 is the only 
protein known to use the amino acid hypusine, a spermine-modified lysine, to stimulate the 
formation of the first peptide bond during the translation process [189; 190].   It has been 
suggested that rather than participating in global translation of proteins, eIF5A2 is specifically 
involved in translation of proteins that are involved in both apoptosis and proliferation in 
endothelial cells [189].   
In addition to eIF5A2, GAPDH has been identified as a target of S-nitrosation in our 
study and several others [77; 159; 175; 176; 177; 178; 179].  There have been many studies of 
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the relationship between GAPDH and caspase independent cell death [191].  Of particular 
interest in this pathway is the relationship between NO, GAPDH and the protein Siah1.  In a 
study using LPS activated macrophages it was shown that NO production leads to S-nitrosation 
of GAPDH [192].  This NO-based modification of GAPDH allows it to bind to Siah1, an E3 
ubiquitin ligase, and using Siah1’s nuclear translocation signal the complex migrates to the 
nucleus.  Under normal conditions Siah1 is rapidly degraded by the ubiquitin proteasome system, 
but it is stabilized by complexing with GAPDH, resulting in increased nuclear protein 
degradation and ultimately cell death via apoptosis [193; 194]. 
In addition to identification of novel targets of S-nitrosation, this study allowed us to 
make comparisons of the utility of our modification of the biotin-switch assay in identifying 
targets of S-nitrosation in endothelial cells using both exogenous and endogenous sources of NO.  
In the first set of studies we used relatively high, non-physiological doses of two well 
characterized NO donors, S-nitrosoalbumin and L-SNCEE [42; 61; 83; 127; 170; 171; 195].  In 
this case, where endothelial cells capable of producing low, steady-state concentrations of NO in 
culture (Figure 3.4) were exposed to large doses of NO from an external source, we were able to 
observe changes in the S-nitrosation state of several cellular proteins.  In contrast, when 
endothelial cells were exposed to a more physiologically relevant source of NO by infection with 
AdiNOS, while overall NO production was increased slightly (Figure 3.4), any changes in the 
spectrum of S-nitrosated proteins were masked by the steady state production of NO by 
endothelial cells in culture.  In addition, we were unable to fully inhibit NO production in 
culture.  These experiments lead us to conclude that the modified biotin-switch method is an 
effective tool to monitor large changes in the S-nitrosation state of proteins, but more subtle 
changes may be lost in the “background” created by steady state NO production in endothelial 
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cells.  Despite the limitations of the assay we were able to use our modified assay to allow more 
efficient proteomic analysis of S-nitrosated proteins from complex mixtures and to identify novel 
targets of S-nitrosation in endothelial cells. 
This technique also allowed us to extend our studies of the potential for S-nitrosation of 
metallothionein.  Previous studies in our laboratory using a fluorescence resonance energy 
transfer-based metallothionein reporter have shown that exposure of this reporter to endogenous 
and exogenous sources of NO results in zinc release from metallothionein and consequent 
unfolding of the reporter construct [60; 61; 62].  We attributed these NO-mediated changes to S-
nitrosation of the protein thiol groups present in MT.  In this study we used our S-nitrosation 
detection assay in combination with immunoblotting to determine that MT is in fact S-nitrosated 
in endothelial cells (Figure 3.1).   These experiments add weight to the conclusions from 
previous studies and indicate that S-nitrosation of thiol residues in MT plays an important role in 
NO-mediated zinc signaling in endothelial cells. 
This study has demonstrated that a modified version of the biotin-switch method may be 
used effectively to screen for NO-mediated changes in the S-nitrosation state of the proteome of 
endothelial cells.  However, this method, like any method based upon the biotin-switch method 
has several caveats.  There are a variety of forms that NO-mediated thiol modification may take 
including glutathionylation and disulfide formation [106].  The biotin-switch method is not 
meant to distinguish between these modifications and a S-nitrosothiol.  In addition, its sensitivity 
has been questioned.  It has been reported that in order to be detected by this method, S-
nitrosothiols must be present in at least nanomole per milligram of protein levels [106; 118].  
Given the potential problems with the biotin-switch method and its derivatives the S-nitrosation 
state of any proteins identified in a proteomic screen must be verified using a secondary method 
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of detection, with mass spectrometry to identify the modification of a specific thiol group being 
the gold standard [77; 94; 196].  Regardless of the limitations of the assay, general consensus 
within the field states that methods derived from the biotin-switch can be valuable screening 
tools if used carefully and if the results are ultimately verified using another method [106; 117].  
As we have demonstrated in this study, a fluorescent modification of the biotin-switch assay has 
allowed us to identify S-nitrosated proteins in endothelial cells using a proteomic approach.  This 
tool will be a valuable addition to the arsenal of S-nitrosoprotein detection techniques and 
ultimately may be used to help us further dissect NO-mediated signaling pathways in endothelial 
cells. 
 
 
 
 
 
 
 
 
   
 64 
4.0  CHAPTER 4:  MEASUREMENT OF PROTEIN S-NITROSOTHIOLS IN THE 
VASCULATURE 
In preparation 
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School of Public Health, Pittsburgh, PA 15260; bDepartment of Surgery, University of Pittsburgh 
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4.1 INTRODUCTION 
In this article we discuss and compare existing methods of S-nitrosothiol detection.  We examine 
traditional S-nitrosothiol detection assays such as flash-photolysis chemiluminescence, chemical 
reduction assays, and fluorometric measurement methods.  However, the main focus of the 
article is on newly emerging methods to examine to S-nitrosoproteome.  We discuss the biotin 
switch method for S-nitrosothiol detection and its potential limitations.  We also present our 
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experience detecting S-nitrosoproteins in endothelial cells and the additional complications that 
working with this cell type adds to S-nitrosothiol detection. 
 
4.2 MANUSCRIPT AS PREPARED FOR SUBMISSION  
4.2.1 Abstract 
This review discusses the measurement of S-nitrosothiols in proteins with an emphasis on 
a recently developed technique that facilitates analysis of the S-nitrosoproteome in tissues and 
cell lines.  Protein S-nitrosation has been proposed as a newly emerging, post-translational 
protein modification-based signaling pathway for nitric oxide.  As researchers continue to 
evaluate the relevance of protein S-nitrosation as a signaling pathway, an understanding of all of 
the tools available for S-nitrosothiol analysis will become increasingly valuable. 
 
4.2.2 Keywords 
Nitrosation 
Biotin Switch 
S-nitrosthiols 
Nitric Oxide 
Thiols 
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4.2.3 Introduction 
Nitric oxide (NO) is formed by nitric oxide synthases (NOSs) as a gaseous free radical.  
Expression of NOS, and therefore production of NO, can be either constitutive or inducible 
[157].  As such, NO’s function varies according to cell type.  In the vasculature NO is produced 
by endothelial NOS and functions as endothelium derived relaxation factor.  This vasodilatory 
function of NO is a result of the classical NO signaling pathway in which NO interacts with the 
heme in guanylate cyclase ultimately leading to increased production of cyclic guanosine 
monophosphate (cGMP).  The increased levels of cGMP activate cGMP-dependent protein 
kinases leading to activation of downstream signaling factors [197].  For many years NO was 
thought to exert its action solely through this role as a diffusible second messenger that affects 
cellular processes strictly through its effect on cGMP levels.  Recently a new NO signaling 
paradigm has emerged.  The S-nitrosation of protein cysteine-thiols is thought to be a new post-
translational protein modification with potential signaling consequences analogous to protein 
modification via phosphorylation [93].   
 
4.2.4 Protein S-nitrosation as a nitric oxide-mediated signaling pathway 
There is mounting evidence that NO can react with proteins to post-translationally 
modify thiol groups.  These modifications are not dependent upon NO itself, but rely on the 
formation of nitric oxide derivatives in biological systems to exert this nitrosating effect [176].  It 
is also prudent to mention that S-nitrosothiols are not the only NO-based modification that may 
be formed in biological systems.  Both the addition of an NO group to tyrosine residues (tyrosine 
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nitration) and methionine oxidation are examples of cGMP-independent NO modifications of 
proteins [34].  In addition to S-nitrosation, cysteine residues may also undergo oxidation to 
sulfenic, sulfinic, and sulfonic acid, or addition of a glutathione moiety (S-glutathionylation) 
[34].  However, in this review we will focus on S-nitrosation of protein thiols.   
There are several theories in the literature regarding the function of protein S-
nitrosothiols.  Many are willing to accept the possibility that protein S-nitrosation represents a 
unique signaling pathway in biological systems [76; 77; 93; 159], however there are other 
arguments proposing that protein S-nitrosothiols serve as a NO transport mechanism via 
transnitrosation or as a NO reservoir in cells [42; 198].  Finally there are groups who propose 
that protein S-nitrosation occurs most prevalently when cells undergo oxidative stress and 
glutathione levels become depleted [199; 200; 201].  In biological systems the reaction between 
NO and thiols is unfavorable, with metal centers and free radicals being kinetically preferable 
targets [202; 203].  Despite the kinetic barriers, S-nitrosothiols can be detected in vivo in both 
normal and pathological conditions [33; 42; 104; 204]. 
  
4.2.5 Formation of S-nitrosothiols in vivo 
There are four main mechanisms by which S-nitrosothiols may be formed in vivo.  The 
first involves the reaction of nitrous acid (HONO) with thiols.  This is in fact the major 
mechanism of S-nitrosothiol formation in vitro [117], but due to the very low pH levels required, 
it is unlikely to contribute significantly to protein S-nitrosation in vivo.  It may be involved in 
formation of S-nitrosothiols in the gastrointestinal tract [117].   
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The second method of S-nitrosothiol formation involves direct addition of a nitrosonium 
cation (NO+) or its equivalent to a thiol group.  There is evidence that peroxidase complexes I 
and II can be reduced by NO and form NO+ [205; 206], however NO+ is very unstable in aqueous 
solution at neutral pH so the target thiol must be in extremely close proximity to the site of NO+ 
production [117].   
The third mechanism of S-nitrosothiol formation is a result of direct nitrosation by N2O3.  
This reaction is relatively fast [117], however formation of N2O3 requires NO to be oxidized to 
NO2 and then to combine with a second NO molecule and this reaction proceeds rather slowly at 
biological concentrations of NO.  Some have suggested that NO and O2 may be concentrated in 
hydrophobic membrane and protein pockets [95; 96] and that this might accelerate the formation 
of N2O3 thereby increasing the relevance of this pathway in protein S-nitrosation in biological 
systems.   
The fourth potential mechanism for formation of protein S-nitrosothiols involves direct 
combination of a NO radical with a thiyl radical in a diffusion rate limited radical-radical 
combination reaction [207; 208].  Since it has been demonstrated that glutathione is able to repair 
other free radicals it is possible that thiyl radicals may be formed as a result of oxidative free 
radical exposure [117].   
Finally, the most important reaction of S-nitrosation when discussing its potential as a 
signaling pathway is the reversible transfer of the nitroso group from an S-nitrosothiol to a target 
thiol.  This reaction is known as transnitrosation.  In most cases the rate of transnitrosation in 
biological systems is determined by the pKa of the attacking thiol group, as pKa is one 
determination of the nucleophilicity of the thiol group [209; 210].  Low molecular weight 
(LMW) thiols are able to modify protein thiols and to convert the protein nitrosothiol back to the 
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original thiol.  The distribution of the S-nitroso groups within a cell will depend upon the rates of 
all possible S-nitrosation reactions within in the cell, which in turn is highly dependent upon the 
pKa of the thiols involved; the lower the thiol pKa, the more likely it is to become a target for 
transnitrosation [209]. 
Rather than being a random process as the discussion above might suggest, protein S-
nitrosation is thought to be restricted to specific thiols on the target protein by several potential 
mechanisms.  The first mechanism stems from the theory that acidic and/or basic amino acids 
surrounding the modified thiol can alter its pKa, rendering it more nucleophilic and therefore 
more susceptible to S-nitrosation [93], as was initially described in the protein hemoglobin [211].  
In other proteins where an acid/base motif has been identified it is composed of flanking acidic 
(Asp, Glu) and basic (Arg, His, Lys) residues [81].  The proximity of the acidic and basic 
residues in the tertiary and/or quaternary structure of the protein is key to the success of the so-
called acid-base motif, as evidenced by recent studies that attempted to predict sites of S-
nitrosylation based solely on the linear amino acid sequence of a particular protein [94].  A 
second mechanism thought to lead to the tight control of S-nitrosation is the subcellular 
compartmentalization of sources of NO and target proteins based upon interactions with nitric 
oxide synthases (NOSs) or NOS associated proteins [81].  Finally, the presence of hydrophobic 
pockets in a protein may also lend specificity to S-nitrosation [91].  This idea is supported by the 
fact that NO and O2 tend to preferentially concentrate in hydrophobic areas, as evidenced by the 
increase in reaction rate between the NO/O2 pair in the hydrophobic environment of the plasma 
membrane [95].  Additional studies have shown that hydrophobic pockets within proteins lead to 
increased S-nitrosation of the cysteine residues found there [96]. 
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4.2.6 Dysregulation of protein S-nitrosation and disease 
There is evidence that an imbalance in protein S-nitrosation may play a role in human 
diseases [30].  Elevated levels of s-nitrosation may contribute to diseases such as arthritis, sepsis, 
preeclampsia, and hypercholesterolemia, while decreased levels of protein S-nitrosation have 
been implicated in diseases such as asthma, cystic fibrosis, and pulmonary hypertension.  In each 
case, it seems as if an alteration in protein post-translational modification (S-nitrosation) may 
result in the malfunctioning of cellular signaling pathways [30]. 
  
4.2.7 Common analytical methods for S-nitrosothiol measurement 
There are a number of challenges to be faced when attempting to measure S-nitrosothiols 
in biological systems mostly due to their very low levels in vivo.  Various reports have been 
made regarding the concentration of S-nitrosothiols in biological systems.  The values range 
between 1.5 – 2 mM in endothelial cells [80] and rat kidney [80] to 10 – 100 nM in various 
tissues as measured by Bryan et al. [212].  This four- to-five order of magnitude gap in various 
measurements in the literature can be seen as an illustration of the difficulty of accurately 
measuring S-nitrosothiols in biological systems.  Since S-nitrosothiols are present at such low 
levels in vivo the presence of nitrite, iron-nitrosyl and other contaminants can serve as significant 
artifacts in any measurement system [105].  An additional complicating factor is introduced 
when one considers the lability of the S-NO bond.  Protein S-NO bonds are extremely sensitive 
to changes in tertiary and quaternary structure of the protein, as well as preparation conditions 
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after extraction [107].  Care must be taken not to extensively modify the level of protein S-
nitrosation through the assay conditions used to quantify protein S-nitrosothiols [213; 214].   
 
4.2.8 S-nitrosothiol detection techniques 
There are a number of detection techniques that are commonly used to measure S-
nitrosothiols (Table 4.1).  We will discuss each of the techniques briefly and their application to 
measurement of protein S-nitrosation in complex mixtures. 
 
Table 4-1 Common S-nitrosothiol detection techniques.  Modified from [108]. 
 
Method Mechanism Detection 
Limit 
Selectivity Pros Cons 
Photolysis-
Chemiluminescence 
[78; 114; 198; 215] 
Photolysis 
induced 
cleavage of S-
NO bond 
pM range Nitrite and iron-
nitrosyls are 
also detected 
Sensitive Equipment is 
very expensive 
Detection of 
false positives 
possible 
Can not detect 
S-nitrosothiols 
in a specific 
protein of 
interest in a 
complex sample 
Reductive 
chemiluminescence 
[110; 114; 216; 
217; 218] 
Copper and 
cysteine 
selectively 
reduce S-NO 
bond 
pM range Selective for S-
nitrosothiols 
Both specific 
and sensitive 
Nitrite can 
interfere with 
assay at low pH 
Presence of 
heme can 
obscure 
detection of S-
nitrosothiols 
Can not detect 
S-nitrosothiols 
in a specific 
protein of 
interest in a 
complex sample 
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Method Mechanism Detection 
Limit 
Selectivity Pros Cons 
Nitrite 
quantification using  
KI 
chemiluminescence 
[110; 114; 219] 
Thiol bound 
NO converted 
to NO+ and 
detected as 
nitrite after 
reduction by KI 
in acidic 
solution 
pM range 
Not selective – 
indirect 
measurement 
Simple assay Not very 
sensitive – 
should not be 
used as stand 
alone assay 
Can not detect 
S-nitrosothiol 
on a particular 
protein of 
interest in a 
complex sample 
Saville assay [209; 
220] 
Thiol bound to 
NO must be 
converted to 
NO+ and is then 
detected using 
Greiss reagent 
Approx 500 nM Selective for S-
nitrosothiols 
Simple and 
inexpensive 
Not a sensitive 
measurement 
Can not detect 
S-nitrosothiols 
in a particular 
protein of 
interest in a 
complex sample 
DAF-based 
fluorescence [217; 
221; 222] 
NO+ based 
conversion of 
DAF to 
fluorescent 
DAF-2T 
nM range 
Gel – based 
methods µM 
range 
Can be sensitive 
depending upon 
conditions 
Can be used in 
high-throughput 
systems 
S-NO must be 
quantified in the 
presence and 
absence of 
HgCl2 
Can not detect 
S-nitrosothiols 
on a particular 
protein of 
interest in a 
complex 
mixture 
Mass spectrometry 
[77; 94; 196; 223; 
224; 225; 226; 227] 
Monitor 
appropriate m/z 
Dependent upon 
instrument 
Usually in 200 
nM range in 
solutions 
Highly selective Highly selective 
If paired with 
LC/MS can 
detect S-
nitrosothiols in 
a particular 
protein of 
interest in a 
complex 
mixture 
Must design LC 
phase to 
stabilize S-NO 
bonds and avoid 
creating new S-
NO bonds 
Must use 
internal 
standards 
labeled with 15N 
Biotin switch 
method [77; 106; 
116; 117] 
Use 
biochemical 
substitution to 
biotinylate S-
nitrosated 
cysteine 
moieties in 
proteins 
 Selective for S-
nitrosothiols 
Selective if 
proper reaction 
conditions and 
controls are 
used 
Can give 
spurious results 
if conditions are 
not carefully 
controlled 
Must be 
verified using a 
second 
detection 
method 
 
Table 4-1 continued  
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The first technique that is often used to measure S-nitrosothiols is photolysis-
chemiluminescence [78; 198].  In this technique the S-N bond of nitrosothiols is homolytically 
cleaved using high intensity UV light to liberate both a NO and a thiyl free radical which is 
detected by reaction with ozone in the gas phase by a nitric oxide analyzer [107].  This process is 
most often used to detect the total amount of S-nitrosothiols in a sample or a purified protein and 
thus is not in itself capable of determining the S-nitrosation status of an individual protein in a 
complex mixture such as the proteome.  In addition, it has been demonstrated that photolysis is 
not necessarily specific for cleavage of the S-NO bond.  It can also release nitroso groups from 
nitrosamine and iron-nitrosyl species, and reduce nitrite to NO in the presence of thiols, which 
can lead to an overestimation of the S-nitrosothiol content of a sample [108; 109].   
A second set of S-nitrosothiol measurement assays depend upon reduction of the S-NO 
bond either with CuCl and cysteine [49; 110; 216; 217] or potassium iodide (KI) [110; 114; 205].  
In the first case NO is measured via reaction with ozone in a nitric oxide analyzer.  In the second 
case the thiol bound NO is detected as nitrite after reduction with and acidic solution of KI.  Both 
of these methods have serious limitations.  In the case of CuCl chemiluminescence the presence 
of nitrite at low pH can be observed as part of the S-nitrosothiol signal.  In addition the presence 
of heme in the assay can mask the S-nitrosothiol signal [107].  In the case of KI reduction, the 
method is simple, but cannot be used as a stand-alone assay [107; 114].  Finally, neither assay 
can be used in analysis of complex mixtures such as the proteome. 
The third method, the Saville-Greiss method, uses conversion of the S-nitrosothiol bond 
to nitrite, which is detected colorimetrically using the Greiss reagent [114; 209; 220].  This 
method is very insensitive, with its limit of detection around the 500 nM range.  It is also not 
applicable to analysis of the proteome. 
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The fourth method is a fluorescence-based assay dependant upon the conversion of non-
fluorescent 4,5-diaminofluorescein (DAF) to fluorescent DAF-2T upon exposure to NO+ [217; 
221; 222].   However, fluorescent methods suffer from lack of specificity and reproducibility 
[104].  In addition, this method is commonly used to identify total S-nitrosothiols in a sample or 
purified protein, making it unsuitable for analysis of individual S-nitrosothiols in a complex 
sample. 
The final commonly used method to analyze S-nitrosothiols in a sample is mass 
spectrometry [77; 92; 94; 196; 223; 224; 225; 227; 228].  Mass spectrometry based methods are 
extremely sensitive, and if samples are processed carefully, very accurate [107].  In addition to 
the sensitivity of these methods, when used in combination with high-pressure liquid 
chromatography they can be used to examine the S-nitrosation status of individual proteins 
within a complex mixture such as the proteome [92; 94].  However, not all researchers have 
access to the mass spectroscopic equipment necessary to perform proteomic analyses strictly 
based upon mass spectroscopic analysis of tissue preparations or cell lysates.  In this case another 
method for analysis of individual S-nitrosoproteins in a complex mixture, known as the Biotin 
Switch Assay [77; 116] offers researchers another alternative. 
4.2.9 The biotin switch assay and modifications 
One of the current methods for identifying s-nitrosated proteins in a complex cellular 
milieu is the biotin-switch assay, developed by Jaffrey et al[77; 116].  The method results in the 
specific labeling of s-nitrosated proteins with a biotin moiety or a fluorescent tag on S-nitrosated 
cysteines [116] (Figure 4.1, noted in black font).   
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Figure 4-1 The Biotin Switch Method for detection of protein S-nitrosothiols.  The steps from the original 
assay are noted in black.  Modifications to the original assay are noted in green. 
 
 
This process involves three sequential steps.  First, free thiols are blocked by incubating protein 
mixtures with methyl methane thiosulfonate (MMTS), a thiol-specific methylating agent.  
Sodium dodecyl sulfate is included to denature proteins and allow MMTS to access internal thiol 
residues.  The remaining protein nitrosothiols are reduced to thiols using ascorbate.  Finally, the 
resultant thiols are reacted with a biotin moiety (N-[6-(biotinamido)hexyl]-3’-(2’-
pyridyldithio)propionamide; biotin-HPDP) resulting in selective labeling of s-nitrosothiols[116].  
Using Western blotting, biotin-labeled proteins can be revealed using an anti-biotin antibody 
[77] or streptavidin-peroxidase[176].  When combined with proteomic approaches, this assay can 
be used to explore the extent of s-nitrosation in tissues or cultured cells. 
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As is the case with other s-nitrosothiol detection methods, the biotin-switch assay has 
several potential pitfalls.  The sensitivity of the assay is dependent upon both the ability to 
effectively block free thiols to render them inert, and the effectiveness of ascorbate as a reducing 
agent.  Both MMTS[77] and N-ethylmaleimide (NEM) [229] have been used to effectively block 
samples, reducing the background upon subsequent Western blotting to very low levels. In 
addition, studies have shown that ascorbate does not reduce all S-nitrosothiols with equal affinity 
[230; 231; 232].  In fact, a recent study by Zhang et al.[118] demonstrated that the sensitivity of 
the biotin-switch assay was dependent upon both ascorbate concentration and incubation time.  It 
has been suggested that reactivity of S-nitrosothiols toward ascorbate may be influenced by 
amino acid sequence, thiol pKa, and steric hindrance [118].  To date these issues have not been 
thoroughly studied, thus it appears that modifications to the original biotin-switch protocol may 
increase sensitivity [118].     
To that end our laboratory and others have made several modifications to the original 
method (Figure 4.1, noted in green font) [92; 94; 117; 118; 175].  Increasing the number of 
MMTS blocking steps in the original protocol can decrease the detection of background signals 
from incomplete blocking.  In addition, increasing the concentration of ascorbate and the 
incubation time used in the reduction step can lead to increased sensitivity in the assay [117; 
118].  Finally, the use of thiol-specific fluorescent labels can increase the efficiency of proteomic 
analyses using the assay (Stitt et al., unpublished data) [117].   
4.2.10 Potential limitations of the biotin switch assay 
There are certain caveats that must be considered whether one uses the original Biotin 
Switch Assay or a modification of the original.  It is important to recognize that the Biotin 
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Switch Assay can serve as a valuable first screening tool to examine the S-nitrosoproteome of a 
particular tissue or cell type.  However there are questions related to the specificity of the assay.  
For example, some groups have discovered that disulfide bonds present in proteins may be 
reduced with ascorbate during the protein processing necessary for the assay and may therefore 
be identified as potential S-nitrosated proteins [233].  It is also possible that the assay may detect 
sulfenic and sulfinic acid thiol modifications as well as cystinylated and glutathionylated proteins 
[106].  Therefore, any experiments performed using this assay must be carefully considered, and 
any potentially nitrosated proteins that are identified using the assay must be confirmed to be S-
nitrosated using another common method of S-nitrosothiol measurement [106; 117; 234]. 
 
4.2.11 The biotin switch assay in endothelial cells 
In addition, when performing studies in vascular cells, particularly endothelial cells, there 
are other considerations that are necessary.  Cultured primary endothelial cells produce NO via 
endothelial nitric oxide synthase [23].  This leads to the formation of a group of S-nitrosated 
proteins that are present as a baseline in every analysis.  This baseline level of S-nitrosated 
proteins can mask subtle changes in the S-nitrosoproteome such as those that might be 
hypothesized to occur upon exposure to increased NO production in inflammation for example 
(Stitt et al., unpublished data).  More substantial changes in the S-nitrosoproteome, such as those 
resulting from exposure to an exogenous NO donor, can be detected with careful use of this 
technique.  The Biotin Switch Assay shows promise, despite its limitations, as a valuable tool to 
analyze the potential effects of S-nitrosoprotein-based signaling pathways in the vasculature. 
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5.0  CHAPTER 5: DISCUSSION 
5.1 NITRIC-OXIDE MEDIATED ZINC HOMEOSTASIS IN ENDOTHELIAL 
CELLS: A ROLE FOR METALLOTHIONEIN AND METAL RESPONSIVE 
TRANSCRIPTION FACTOR-1 
It is known that S-nitrosation of cysteine residues capable of forming zinc complexes is an 
important component of NO-mediated signaling, and that MT is capable of forming a link 
between NO and cellular zinc homeostasis [60; 61; 62; 75].  In this study we have demonstrated 
that MTF-1 can serve as a component of the MT-zinc signaling pathway by affecting gene 
expression (Chapter 2).  There is evidence in the literature that metals and oxidants can activate 
MTF-1 by redistributing zinc within the cell, and thereby activating expression of MT, one of the 
best-known gene targets for MTF-1 [67; 72; 74; 138; 143].  We have demonstrated that NO 
increases labile zinc levels in pulmonary endothelial cells [62], and that this causes MTF-1 to 
translocate to the nucleus of cells (Chapter 2, Figures 2.1-2.3).  We used cells derived from MT-
null mice to demonstrate that there was no NO-mediated zinc release or MTF-1 translocation, 
which indicates that MT plays a central role in this process.   
It has been shown that NOS-derived NO and NO donors are both able to increase MT 
mRNA expression in bovine aortic endothelial cells [75].  We extended these finding by 
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demonstrating that exposing sheep pulmonary artery endothelial cells to NO increases the 
expression of MT protein and causes nuclear translocation of MTF-1.   
We previously reported that S-nitrosation of the cysteine groups in metallothionein is a 
critical component of cellular redox state that links NO to Zn homeostasis in pulmonary 
endothelial cells [60; 61; 62].  In this study we have demonstrated that NO-induced changes in 
labile zinc activate the zinc-sensitive transcription factor MTF-1.  It is known that NO may either 
contribute to or prevent apoptosis [154; 155].  We speculate that the NO-induced activation of 
MTF-1, which leads to increased expression of cytoprotective genes, may contribute to the anti-
apoptotic effects of NO. 
5.2 EXAMINATION OF THE S-NITROSOPROTEOME OF PULMONARY 
ENDOTHELIAL CELLS 
We extended our studies of the effect of NO and post-translational S-nitrosation of protein thiol 
residues to the examination of the S-nitrosoproteome of pulmonary endothelial cells.  We first 
developed a fluorescent modification of the biotin switch assay [77; 116] that allowed us to 
directly detect S-nitrosated proteins in a two-dimensional gel format and use peptide mass 
fingerprinting to identify potential proteins of interest (Chapter 3).  We first used this technique 
to examine the S-nitrosation status of MT in sheep pulmonary artery endothelial cells exposed to 
NO donor (Chapter 3, Figure 3.1).  We were able to use a combination of immunoblotting and 
two-dimensional gel electrophoresis to demonstrate that MT is in fact nitrosated in pulmonary 
endothelium exposed to NO donor.  This reinforces our previous studies where we determined 
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that NO-based modification of the zinc-thiolate clusters in MT are a critical link between NO 
and zinc homeostasis in pulmonary endothelial cells [60; 61; 62].   
We then extended our studies of protein S-nitrosation to five different endothelial cell 
types from four different species (human pulmonary artery endothelial cells, mouse lung 
endothelial cells, rat pulmonary artery endothelial cells, rat microvascular endothelial cells and 
sheep pulmonary artery endothelial cells) and used our fluorescent modification of the biotin 
switch technique to identify potential proteins of interest.  The first observation of note is that the 
spectrum of proteins identified from endothelial cells of different species exposed to two 
different NO donors, L-SNCEE and S-nitrosoalbumin, is relatively consistent (Chapter 3, Tables 
3.1-3.4).  Since endothelial cells in culture are capable of producing NO (Chapter 3, Figure 3.4) 
this is not especially surprising.  In fact when the results from all species of endothelial cells 
examined in this study are combined, several groups of proteins appear as particularly prominent 
targets of S-nitrosation including cytoskeletal, chaperone, and glycolytic proteins (Chapter 3, 
Figure 3.3).   
We also examined the profile of S-nitrosated proteins in sheep pulmonary artery cells 
where NO production was modified by infection with an adenoviral vector expressing the cDNA 
for human iNOS (AdiNOS).  Because endothelial cells in culture produce NO (Chapter 3, Figure 
3.4) there was a significant level of protein S-nitrosation in uninfected cells (SPAEC; Chapter 3, 
Figure 3.5).  Increased NO production via infection with AdiNOS (Chapter 3, Figure 3.4) did not 
result in any appreciable changes in the spectrum of S-nitrosated proteins (Chapter 3, Figure 
3.5).  In addition, both uninfected and infected cells treated with the NOS inhibitor L-NAME 
showed a similar profile of S-nitrosated proteins when compared to uninfected and infected 
controls (Chapter 3, Figure 3.5).  This is most likely due to the fact that even in the presence of 
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L-NAME sheep pulmonary artery endothelial cells are capable of producing NO (Chapter 3, 
Figure 3.4).   
It is our experience that, in endothelial cells, a fluorescent modification of the biotin 
switch method can be used to discern large changes in protein S-nitrosation (such as those 
changes caused by exposure to NO donors).  However, it appears that baseline NO production in 
these cells can obscure smaller changes in protein S-nitrosation (such as those changes caused by 
increased NO production via expression of iNOS).   
Regardless of the limitations encountered in our work with endothelial cells, we were 
able to identify new potential targets of protein S-nitrosation in this cell type.  It will be 
necessary to verify that the potential targets that we have identified are indeed S-nitrosated using 
another method for measurement of protein S-nitrosothiols.  However, we have developed a 
useful screening technique to determine levels of protein S-nitrosation in a variety of endothelial 
cells types.  It is our hope that this work will contribute a new perspective to the function of S-
nitrosothiol modifications as a signaling pathway and ultimately lead to increased understanding 
of how dysregulation of this pathway may contribute to diseases such as asthma, pulmonary 
hypertension and sepsis. 
5.3 FUTURE DIRECTIONS:  DISSECTING S-NITROSATION AS A POTENTIAL 
SIGNALING PATHWAY 
There is a great deal of focus on the potential for S-nitrosation to serve as a post-translational 
signaling pathway somewhat analogous to protein phosphorylation.  However, most studies thus 
far have been screening experiments meant to determine the extent of the S-nitrosoproteome in 
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various cell types and conditions.  There is a need for more focused efforts in order to determine 
whether S-nitrosation can indeed function as a signaling pathway as opposed to serving as a 
biomarker for oxidative and nitrosative stress. 
There are some studies demonstrating that S-nitrosation is capable of playing a role in 
specific signaling pathways.  For example, the studies of the GAPDH/Siah1 interaction 
demonstrate a clear role for modification of a particular thiol group leading to downstream 
effects including apoptosis [191; 192; 193; 194].  In these studies it has been demonstrated that 
S-nitrosation of a particular thiol in GAPDH results in formation of a complex with the ubiquitin 
ligase Siah1.  The complex uses the nuclear localization signal located in Siah1 to translocate to 
the nucleus, where protein degradation is increased, ultimately leading to caspase independent 
cell death via apoptosis.  In this case there is a specific nitrosative signal that leads to clear 
downstream effects.  The question that remains is one of dissecting the potential signaling 
interactions of proteins identified by screening methods such as the Biotin Switch Method and its 
modifications. 
There are several possible methods available to researchers wishing to examine the role 
of potential protein targets of S-nitrosation in more detail.  The first step in these endeavors is to 
verify the S-nitrosation status of the proteins identified in a screen.  Traditional methods of S-
nitrosothiol detection, such as flash-photolysis chemiluminescence or mass spectroscopy should 
be used to verify the addition of an NO moiety to a protein.  These approaches are challenging 
since most require purification of the protein before a true measure of its S-nitrosation status can 
be made.  In this case, mass spectrometry may prove to be the most useful verification method.  
S-nitrosothiols in proteins from total cellular extracts can be substituted using a modification of 
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the Biotin Switch Method, separated by liquid chromatography, and the substituted peptide can 
be identified by mass spectroscopy [92; 94].   
Regardless of the method used to confirm the presence of a nitric oxide-mediated protein 
modification, the next step in a careful analysis would be to determine protein interaction 
partners that may be dependent upon the S-nitrosothiol modification.  There are several 
approaches that may be used to accomplish this.  It is possible to use a traditional 
immunoprecipiation method using an antibody against the NO-modified protein to pull down 
potential protein partners.  In addition, a method based upon a yeast two-hybrid screening system 
has been adopted to identify protein interactions that are dependent upon NO-mediated 
modifications [235].  The method uses a yeast strain in which the yeast flavohemoglobin has 
been deleted in order to prevent it from scavenging NO.  The method is analogous to a traditional 
yeast two-hybrid system in which the S-nitrosothiol-modified protein is used as bait and 
screened against a “prey” library with one extra step.  During the screening process the bait and 
prey proteins are exposed to a NO donor in order to identify nitric oxide-mediated protein 
interactions [235].  The authors were able to use this technique to identify NO-dependent 
interactions between procaspase 3, a known target of S-nitrosation, and the proteins acid 
sphingomyelinase and nitric oxide synthase [235].  This method is a promising tool that could be 
used to identify protein partners for other proteins identified in screening of the S-
nitrosoproteome. 
However, the ultimate confirmation of a role for S-nitrosation of a particular protein thiol 
in a NO-based signaling pathway involves site directed mutagenesis of the modified cysteine 
thiol.  If mutation of the proposed target cysteine abrogates S-nitrosation of the protein and 
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interaction with its potential protein partners then one can be confident that the cysteine residue 
in question plays an important role in a potential nitric oxide-mediated signaling pathway. 
We are still in the beginning stages of understanding the role that nitric oxide may play in 
cellular signaling.  Screening experiments using the Biotin Switch Method and modifications 
thereof have presented the field with a large number of potential target proteins.  The present 
challenge to the field is to determine whether S-nitrosated proteins present in the cell play a 
meaningful role in signaling or are an artifact of altered redox status.  The techniques mentioned 
above, if carefully applied, may answer some of the outstanding questions regarding nitric oxide-
mediated post-translations protein modifications as a true signaling pathway analogous to protein 
phosphorylation.   
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A.1.1 Abstract 
We hypothesized that: (a) S-nitrosylation of metallothionein (MT) is a component of pulmonary 
endothelial cell nitric oxide (NO) signaling that is associated with an increase in labile zinc; and 
(b) NO mediated increases in labile zinc in turn reduce the sensitivity of pulmonary endothelium 
to LPS-induced apoptosis.  We used micro spectrofluorometric techniques to show that exposing 
mouse lung endothelial cells (MLEC) to the NO-donor, S-nitrosocysteine, resulted in a 45% 
increase in fluorescence of the Zn2+-specific fluorophore, Zinquin, that was rapidly reversed by 
exposure to the Zn2+ chelator, NNN’N’-tetrakis-(2-pyridylmethyl)ethylenediamine (TPEN).  The 
absence of a NO-mediated increase in labile Zn2+ in MLEC from MT-I and MT-II knockout 
mice inferred a critical role for MT in the regulation of Zn2+ homeostasis by NO.  Furthermore, 
we found that prior exposure of cultured endothelial cells from sheep pulmonary artery 
(SPAEC), to the NO-donor, S-nitroso-N-acetylpenicillamine (SNAP) reduced their sensitivity to 
lipopolysaccharide (LPS) induced apoptosis.  The anti-apoptotic effects of NO were significantly 
inhibited by Zn2+ chelation with low doses of TPEN (10 µM).  Collectively, these data suggest 
that S-nitrosylation of MT is associated with an increase in labile (TPEN chelatable) zinc and 
NO-mediated MT dependent zinc release is associated with reduced sensitivity to LPS-induced 
apoptosis in pulmonary endothelium (Mol Cell Biochem 234/235:  211-217, 2002) 
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A.1.2 Keywords 
Live cell imaging 
Zinquin 
S-nitrosylation 
A.1.3 Introduction 
Nitric oxide (NO) is a diffusible, multifaceted trans-cellular messenger that is recognized to exert 
its influence on a myriad of biological functions in a guanylyl cyclase-dependent fashion.  
However, it has become increasingly apparent that post-translational modifications of proteins, 
in a guanylyl cyclase-independent fashion, may also contribute to the diverse actions of NO.  
Covalent attachment of NO groups to protein sulphydryl groups is one such important post-
translational modification and over 100 candidates for S-nitrosylation have now been identified 
[159].  We have recently shown that S-nitrosylation of zinc thiolate clusters in the metal-binding 
protein, metallothionein (MT), is a crucial component of cellular redox sensitivity linking NO to 
zinc homeostasis in pulmonary endothelial cells [60; 62]. 
 Recent data shows that NO can act as an anti-inflammatory cyto-protective molecule in a 
number of different cell types [154].  Endogenous NO synthesis or exposure to low levels of NO 
donors reduces the sensitivity of cultured endothelial cells to lipopolysaccharide (LPS) induced 
apoptosis [23; 26].  Although the mechanism remains unclear, in other cell types, the anti-
apoptotic effects of NO appear to be associated with increased expression of stress genes such as 
heat shock proteins [236] and BCL-2 [237], changes in metal (Fe) ion homeostasis [236] and/or 
guanylyl cyclase-independent modification of Fas ligand signaling pathways by S-nitrosylation 
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of caspases [238; 239].  We propose that a novel intracellular signaling pathway, S-nitrosylation 
of zinc-thiolate clusters, may contribute to the NO-mediated inhibition of LPS-induced apoptosis 
in cultured endothelial cells.  In this regard, zinc, the first known inhibitor of apoptosis [240], 
may be a candidate molecule in mediating the sensitivity of endothelial cells to pro-apoptotic 
stimuli after NO.  This hypothesis is based on separate reports showing that exposure to NO 
donors increases intracellular zinc [59; 62; 135] and that Zn2+ chelation enhances LPS-induced 
apoptosis in cultured endothelial cells [120].  We have also shown that the major zinc binding 
protein, metallothionein, is required for NO-mediated zinc release in cultured fibroblasts [62].  
However, given that endothelium is a critical locus of the L-arginine-NO biosynthetic pathway, 
and has been the focus of early structural and functional changes in a variety of pro-oxidative 
conditions, many of which are affected by the simultaneous production of nitric oxide, it was 
important to determine the importance of MT in affecting changes in labile zinc in endothelial 
cells, in addition to investigating a role for such alterations in intracellular Zn2+ in the anti-
apoptotic actions of NO. 
 In the present communication, we used live cell imaging of cultured endothelial cells 
isolated from the lungs of wildtype (MT +/+) and MT null mutant mice (MT -/-) to show that 
MT plays a central role in mediating NO-induced changes in labile Zn2+ in pulmonary 
endothelium.  Furthermore, we demonstrated that NO-mediated inhibition of apoptosis is 
reversed with the Zn2+ chelator TPEN, suggesting that NO-induced release of Zn2+ from MT 
could be a contributing factor underlying the anti-apoptotic effects of NO. 
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A.1.4 Materials and methods 
A.1.5 MT knockout mice 
Breeding pairs of MT-I and MT-II deficient mice (MT-/-) were imported from Michalska and 
Choo [241].  The mice were of a mixed genetic background of OLA129 and C57BL6 strains.  To 
dilute the OLA129 genetic contribution, MT -/- mice were bred with C57BL6 mice obtained 
from Jackson Immunoresearch Laboratories (West Grove, PA, USA) to generate a parental 
heterozygous chimera that in turn was backbred to C57BL6 wild type.  This backbreeding 
resulted in ≈ 50% offspring that were heterozygous mutants.  These mutants were identified 
through a genotyping protocol using polymerase chain reaction strategy on novel sites within the 
murine MT-II gene that was mutated.  Additional rounds of interbreeding and genotyping 
resulted in F2 generation of MT +/+ and MT -/- mice, which allowed the establishment of 
breeding colonies in which the genetic contributions of the two strains were assumed to be 
similar. 
A.1.6 Cultured murine lung endothelial cells 
MT +/+ and MT -/- endothelial cells were isolated by modifications of an immunobead protocol 
[242].  Briefly, mice lungs were rinsed in PBS, finely minced and digested in collagenase (Type 
I, 100 µg/ml) for 60 minutes at 37°C with occasional agitation.  The mixture was filtered through 
100 µm cell strainer, centrifuged and washed twice in medium.  Cell suspensions were incubated 
with a monoclonal antibody (rat anti-mouse) to platelet endothelial cell adhesion molecule-1 
(PECAM-1, BD Pharminigen, San Diego, CA, USA) for 30 minutes at 4°C.  Constitutive 
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expression of PECAM-1 is a fundamental characteristic of endothelial cells and has been used 
extensively as a reliable marker to isolate endothelial cells [242].  The cells were washed twice 
with buffer to remove unbound antibody, and resuspended in binding buffer containing the 
appropriate number of washed magnetic beads coated with sheep anti-rat IgG (Dynal, Oslo, 
Norway) to give the desired 30:1 bead to cell ratio.  Attached cells were washed 4-5 times in cell 
culture medium, and then were digested with trypsin/EDTA to detach the beads.  Bead-free cells 
were centrifuged and resuspended for culture.  At approximately passage 2, cells were incubated 
with fluorescent-labeled di-acetylated LDL (dil-LDL), which is taken up only by endothelial 
cells and macrophages, and sorted to homogeneity by FACS.  The enriched PECAM and dil-
LDL population were subcultured in DMEM/F-12, 20% fetal bovine serum, 6% plasma-derived 
human serum, 2 mM glutamine, and 30 µg/ml endothelial derived growth factor. 
A.1.7 Cultured sheep pulmonary artery endothelial cells (SPAEC) 
SPAEC were cultured from sheep pulmonary arteries obtained from a nearby slaughterhouse as 
previously described [128] and grown in OptiMEM (GIBCO BRL, Life Technologies, Grand 
Island, NY, USA) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 
µg/ml streptomycin at 37°C in an atmosphere of 5% CO2. 
A.1.8 Fluorescent microscopy 
MT +/+ and MT -/- endothelial cells were plated onto 31 mm glass coverslips (VWR Scientific, 
West Chester, PA, USA).  Cells were washed with PBS and incubated with 15-30 µM Zinquin 
(Toronto Research Chemicals, Toronto, ON, Canada) for 20 minutes at 37°C.  All recording 
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were performed at room temperature (20-25°C).  Cells were imaged using a PC-based system 
consisting of a Nikon Diaphot 300 microscope equipped with a quartz 40X oil immersion 
objective, a CCD camera (Hamamatsu Photonics, Hamamatsu City, Japan), SimplePCI software 
from Compix (Cranberry, PA, USA) and a monochromator-driven xenon light source (ASI, 
Eugene, OR, USA).  Zinquin was illuminated at 350 nm; light was passed through a400 nm 
dichromatic mirror, and emitted fluorescence was filtered through a 510 ± 40 nm bandpass 
emission filter (Omega Optical, Brattleboro, VT, USA).  For analysis of images, background 
illumination was subtracted from the readings and fluorescent intensity was expressed relative to 
baseline measurements.  Cells were exposed to the NO donor S-nitrosocysteine (SNOC, 2 mM) 
and time-dependent changes in Zinquin fluorescence were monitored as an index of labile Zn2+.,  
Cells were also exposed to 100 µM Zn2+ (in the presence of 10 µM pyrithione) and the zinc-
specific chelator N, N, N’, N’-tetrakis (2-pyridylmethyl)ethylenediamine (TPEN, Sigma, St. 
Louis, MO, USA) as positive controls and denitrosylated SNOC for negative controls.  Each 
experiment was repeated on separate coverslips a minimun of 3 times per cell type. 
 
A.1.9 Lipopolysaccharide (LPS)-induced apoptosis 
 
 
SPAEC were exposed to 0.1 µg/ml LPS (Escherichia coli 0111:B4, Sigma) for 12 h and 
apoptosis was quantified by Hoechst 33342 (1 µg/ml; Molecular Probes, Eugene, OR, USA) 
fluorescent staining [243].  The sensitivity of SPAEC to LPS was reassessed following pre-
treatment with the NO-donor S-nitroso-N-acetylpenicillamine (SNAP; Sigma, St. Louis, MO, 
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USA; 500 µM) for 6 h prior to and during LPS exposure.  The contribution of Zn to NO 
mediated LPS resistance was then determined by repeating this latter experiment in the presence 
of TPEN (10 µM). 
A.1.10 NO-induced cytotoxicity 
SPAEC were incubated 1-10 µM SNAP for 24 h or 0-10 mM SNOC for 2 h.  Toxicity was 
assessed by incubating the cells with the oxidized form of the fluorogenic compound Alamar 
Blue (Accumed, Chicago, IL, USA) and determining the change in fluorescence emission due to 
cellular reduction via mitochondrial respiration as previously described [244].   
A.2 RESULTS 
A.2.1 Effects of NO on zinc homeostasis in endothelial cells 
We used the Zn2+-specific fluorophore, Zinquin [245; 246] to image labile Zn2+.  As reported in 
other cell types [62; 135; 247], lung endothelial cells isolated from both MT +/+ and MT -/- mice 
showed discrete areas of strong fluorescence within the cytoplasm (Fig. A.1). 
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Figure A 1 Zinquin fluorescence measured in mouse lung endothelial cells.  Wild-type (MT +/+) cells 
under control conditions (top panel) and following exposure to 2 mM SNOC (bottom panel). 
 
Unlike pulmonary artery endothelial cells isolated from sheep, or mouse lung fibroblasts [62], 
mouse lung endothelial cells also showed low amounts of diffuse fluorescence in the nucleus.  
When MT +/+ were exposed to 2 mM SNOC there was a prompt and gradual increase in 
fluorescence above baseline levels (Figs A.1 and A.2) that returned to levels below control with 
the application of the Zn2+-chelator, TPEN (Fig. A.2A). 
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Figure A 2 Zinquin fluorescence in lung endothelial cells from MT +/+ and MT -/- mice.  S-nitrosocystein 
(SNOC, 2 mM) increased Zinquin fluorescence in lung endothelial cells isolated from MT +/+ mice (A), but had no 
effect in endothelial cells from MT -/- mice (B).  Each experiment is represented by a single trace from multiple 
cells, and experiments were repeared 3 or 4 times per condition. 
 
This response was consistent in 3 separate experiments (approximately 3-5 cells per experiment) 
and averaged a 44.9 ± 3.1% (SD) increase above baseline fluorescence in response to SNOC.  In 
contrast, there was no increase in fluorescent intensity in response to repeated applications of 2 
mM SNOC (> 10 cells, mean change = 8.2 ± 2.1%) in endothelial cells from MT knockout mice 
(Fig. A.2B) suggesting that MT was central to the changes in labile Zn2+ observed in MT +/+. 
A.2.2 Effects of NO on LPS-induced apoptosis in endothelial cells 
As previously reported [23; 120], exposure of endothelial cells to 0.1 µg/ml LPS (12 h) resulted 
in a significant increase in apoptosis (Fig A.3). 
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Figure A 3 Apoptosis in SPAEC exposed to LPS.  Sheep pulmonary artery endothelial cells (SPAEC) were 
exposed to 0.1 µg/ml LPS for 12 h and apoptosis determined by Hoescht 33342 staining and fluorescence chromatin 
determination and quantification.  The protective effects of NO on LPS-induced apoptosis were assessed by pre-
treatment with 500 µM SNAP.  This protection was reversed by the application of 10 µM TPEN.  * indicate a 
significant difference from LPS alone (P<0.05). 
 
However, SPAEC that were pretreated with the NO donor, SNAP (500 µM) showed decreased 
sensitivity to LPS-induced apoptosis.  This protective effect of NO was significantly inhibited by 
zinc chelation with TPEN (10 µM).  Exposure to this low level of  TPEN is sufficient to decrease 
labile zinc [120] but is not significantly toxic to SPAEC.  However, higher concentrations of 
TPEN (> 10 µM) were previously shown to induce a concentration-dependent decrease in 
viability and increase in apoptosis in pulmonary endothelial cells [120]. 
 While high concentrations of NO donors are toxic in other cell types, a 24 h exposure to 
500 µM SNAP did not affect the viability of cultured SPAEC (Fig. A.4). 
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Figure A 4 Cytotoxicity of NO donors in SPAEC.  Sheep pulmonary endothelial cells (SPAEC) were 
incubated with 0-10 mM SNAP for 24 h or 0-10 mM SNOC for 2 h and cell viability was assessed with Alamar 
Blue. 
 
We also examined the sensitivity of SPAEC to SNOC.  Given the short half-life of this NO 
donor (~ 3 min), we assessed cytotoxicity after 2 h and showed that endothelial cells were 
remarkably resistant to high levels of SNOC with only a 30-40% decrease in cell viability at 
concentrations in excess of 2 mM. 
A.3 DISCUSSION 
Recent evidence suggests that S-nitrosylation of zinc sulfur clusters is an important component 
of NO signaling [59; 60; 62; 248] and our present data confirms that metallothionein is a critical 
link between NO and intracellular zinc homeostasis in pulmonary endothelium.  Furthermore, we 
found that exposure of endothelial cells to low doses of NO reduced their sensitivity to 
subsequent LPS exposure and showed that these anti-apoptotic effects of NO were sensitive to 
Zn2+ chelation by TPEN.  Collectively, these data suggest that MT is a critical compartment for 
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labile Zn2+ and this function is important for the physiologic roles of both MT and NO in 
protecting the cell from oxidative stress. 
A.3.1 Nitric oxide and apoptosis 
The NO donors S-nitrosocysteine (SNOC) and S-nitroso-N-acetylpenicillamine (SNAP) 
spontaneously decompose to generate NO and disulfide.  SNOC decays with a half-life in the 
range of 2-3 min whereas SNAP has a longer half-life on the order of several hours [248].  While 
the concentrations of SNOC (2 mM) or SNAP (500 µM) used in these experiments appear 
relatively high, measurements made of the rate of decomposition of these donors [151] and/or 
free NO concentrations [249; 250] suggest that the [NO] generated by either SNOC or SNAP is 
actually 2-3 orders of magnitude less than the donor concentration.  In addition, the release 
kinetics of SNOC suggest that cell cultures are exposed to a burst of NO, most of which is auto-
oxidized or has reacted with media components before reaching the target cells at the bottom of 
the culture dish [134].  We would therefore expect the actual [NO] to be much closer to 
physiological levels reported to be in the nanomolar range under resting conditions [251] and as 
high as 1.3 µM following stimulation with bradykinin, as measured directly with phorphyrinic 
sensors positioned in situ at the endothelial surface of rabbit aorta [252].   
High concentrations of NO donors have been shown to induce apopotosis in a number of 
cell types, including macrophages, pancreatic islets and certain neurons [154].  In other cell 
types, even low levels of NO can cause necrotic cell death [253; 254].  However, we have shown 
that pulmonary endothelial cells are remarkably resistant to NO-induce cytotoxicity.  In general, 
if a cell is depleted of GSH and is undergoing oxidative stress, then exposure to large amounts of 
NO invariably leads to cell death.  In contrast, in a cell with a more favorable redox status, 
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physiologically relevant levels of NO have been shown to suppress apoptosis in a variety of cell 
types, induced by a number of stimuli, including TNF, oxidative stress and growth factor 
withdrawal [154].  This effect may be guanylyl cyclase dependent or independent.  In the latter 
case, NO appears capable of inducing stress genes that account for decreased apoptosis [236].  
NO can also nitrosylate caspase-3 and thus interfere with the apoptotic pathway [239; 255].  This 
phenomenon was originally noted in cultured endothelial cells that became resistant to LPS-
induced apoptosis when synthesizing NO after direct gene transfer of human inducible nitric 
oxide synthase (iNOS) [23; 26].  In the present study, the anti-apoptotic effects of NO were 
TPEN-sensitive, suggesting that NO-mediated resistance to LPS involved zinc itself or zinc-
dependent downstream targets. 
A.3.2 Measurement of labile zinc 
After iron, zinc is the major intracellular metal, but its free concentration is maintained at 
extraordinarily low levels by the actions of various zinc transporters, vesicular storage sites and 
metal binding proteins of which MT is a major contributor.  Nevertheless, it is this labile pool of 
Zn2+ that appears to be critical in affecting various cellular processes.  Zinquin ester [245; 246] is 
a quinoline-based, non-fluorescent, membrane permeable fluorophore that becomes strongly 
fluorescent upon specific binding to Zn2+ and can thus be used to assess the intracellular 
disposition of chelatable Zn2+ with detection limits that range from 4 pM to 100 nM [256]. 
 The present data confirmed that NO-induced increases in labile Zn2+ are dependent upon 
metallothionein in pulmonary endothelial cells, as shown previously in fibroblasts [62], and 
suggested by the NO-induced conformational changes in green fluorescent protein modified 
metallothionein [60].  In vitro studies using raman spectroscopy suggest that the NO generated 
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by SNOC mediates Zn2+ release from MT via nitrosylation of cysteine thiol groups and 
subsequent disulfide formation [59]. 
A.3.3 Zinc and apoptosis in pulmonary endothelium 
Recent studies using Zinquin revealed labile pools of zinc in pulmonary endothelium [120] and 
epithelium [247] and chelation of Zn2+ resulted in spontaneous apoptosis in both cell types.  We 
recently reported that, like many other cell types, including systemic endothelial cells [257; 258; 
259; 260], zinc chelation enhanced LPS-induced apoptosis [120].  We now show that chelation 
of Zn2+ by TPEN inhibited the anti-apoptotic effects of NO pre-exposure in pulmonary 
endothelial cells.  These data are consistent with the findings of Hennig [259; 260; 261] and 
others [262; 263] who have shown that culturing systemic endothelial cells in zinc depleted 
medium or exposing these cells to TPEN enhanced their sensitivity to various pro-apoptotic 
stimuli.  For example, in cultured aortic endothelial cells, zinc can block cadmium- [262], 
cholesterol- [264] and linoleic acid and TNF-alpha [261] induced apoptosis.  The results are not 
surprising given the fact that zinc was the first molecule shown to inhibit apoptosis.  It was 
initially thought that Zn2+ directly inhibited Ca2+/Mg2+-dependent endonucleases [265].  More 
recent data suggests that zinc affects the activity [266] or processing [267; 268] of caspase-3, a 
critical protease in apoptosis.  Zn2+ itself is redox inert, but it is associated with an extraordinary 
large number of proteins (estimated between 1-10% of the human genome) and is thus an 
integral component of numerous metalloenzymes, structural proteins, and transcription factors.  
As such, it is highly likely that there are alternative pathways mediating the zinc-dependent, anti-
apoptotic effects of NO that could even involve DNA synthesis and the expression of protective 
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genes.  Future work should be directed towards identification of the critical targets for zinc 
following NO-induced release from MT. 
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B.1.1 Abstract 
Low-molecular-weight S-nitrosothiols are found in many tissues and affect a diverse array of 
signaling pathways via decomposition to •NO or exchange of their –NO function with thiol-
containing proteins (transnitrosation).  We used spectral laser scanning confocal imaging to 
visualize the effects of D- and L-stereoisomers of S-nitrosocysteine ethyl ester (SNCEE) on 
fluorescence resonance energy transfer (FRET)-based reporters that are targets for the following 
NO-related modifications: (a) S-nitrosation, via the cysteine-rich protein metallothionein (FRET-
MT), and (b) nitrosyl–heme–Fe, via guanosine 3’,5’-cyclic monophosphate (cygnet-2). 
Conformational changes consistent with S-nitrosation of FRET-MT were specific to L-SNCEE. 
In addition, they were reversed by dithiothreitol (DTT) but unaffected by exogenous 
oxyhemoglobin. In contrast, D- and L-SNCEE had comparable effects on cygnet-2, likely via 
activation of soluble guanylyl cyclase (sGC) by •NO as they were sensitive to the sGC inhibitor 
1H-[1,2,4]-oxadiazolo[4,3-a]quinoxalin-1-one and exogenous oxyhemoglobin. These data 
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demonstrate the utility of spectral laser scanning confocal imaging in revealing subtle aspects of 
NO signal transduction in live cells. Stereoselective transnitrosation of MT emphasizes the 
specificity of posttranslational modification as a component of NO signaling. 
B.1.2 Keywords 
Nitrosothiol, Metallothionein, Guanosine 3’,5’-cyclic monophosphate, Live cell imaging, Green 
fluorescent protein, S-nitrosation, Free radicals 
B.1.3 Introduction 
S-nitrosothiols are adducts of nitric oxide (•NO) and thiol-containing compounds that are found 
in many mammalian tissues and are suggested to affect a diverse array of physiological 
functions, including signal transduction and immune responses [269]. The bioactivities of low-
molecular-weight S-nitrosothiols may be mediated either by their decomposition to •NO or by 
direct exchange of their –NO function with thiol-containingproteins (transnitrosation) [34]. 
Detection of interactions between target proteins and nitrogen oxide species in vivo typically 
requires disruptive biochemical techniques that preclude or limit temporal–spatial information.  
Although significant technological advancements have promoted an increased reliance on the use 
of high performance multimodal optical imaging tools to visualize cellular processes in 
biological systems, the imaging of NO-based signaling events remains especially challenging.  
One successful example is the use of spatial–spectral electron paramagnetic resonance imaging, 
in combination with isotope tracer methods, to map nitrite-derived NO production in the isolated 
ischemic rat heart [270]. More recently, the fluorescent indicator 4,5-diaminofluorescein [271; 
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272] has been widely used for detectionand imaging of •NO but is hampered by concerns 
regarding its selectivity [273; 274], sensitivity [273], and interactions with divalent cations [275].  
Fluorescence resonance energy transfer (FRET) is a nondestructive spectrofluorometric 
technique. In combination with scanning laser confocal microscopy, FRET is capable of 
detecting changes in the conformational state of proteins in live cells. The validity of FRETbased 
approaches to studying intracellular signaling pathways in live cells has been demonstrated using 
fluorescent reporter molecules for calcium [276], guanosine 3’,5’-cyclic monophosphate (cGMP) 
[277], 3’,5’cyclic adenosine monophosphate [278], and tyrosine kinase activity [279], among 
others. Our recent efforts utilizing this methodology to elucidate the role of metallothioneins 
(MT) in nitric oxide signaling [60; 62] suggest that FRET is suitable for detection of 
posttranslational protein modifications caused by NO-related species. 
FRET is a physicochemical phenomenon whereby two fluorophores (i.e., donor and 
acceptor pair) that have appropriate spectral properties and are closely apposed (less than 10 nm) 
transfer photoelectric energy in a nonradiative fashion.  Established methods for detecting 
FRET between a donor and an acceptor with overlapping excitation and emission spectra require 
the use of narrow detection bands and automatic switching of optical filters to differentiate 
between emissions, along with complex mathematical corrections to account for cross talk 
between channels. Recent advances in detector technology, however, now enable the resolution 
of fluorescent images providing full spectral information for each voxel of the image without 
switching of optical filters. Furthermore, using calibration spectra, it is possible to 
unambiguously separate the cross talk between overlapping cyan and yellow emissions. The use 
of this method allows the detection of small, but potentially biologically meaningful, changes in 
FRET that are common with genetically encoded reporters and are extremely difficult to resolve 
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reliably using more traditional methods relying on bandpass filters. 
We used this spectral resolution approach to visualize the effects of membrane-permeant 
forms (ethyl esters) of the D- and L-stereoisomers of S-nitrosocysteine on FRET-based reporters 
for cGMP (cygnet-2) [277] and for the cysteine-rich, metal-binding protein metallothionein 
(FRET-MT). We hypothesized that different effects of SNCEE on the two FRET reporters would 
distinguish between signaling events that are mediated by the free radical •NO, as is best 
exemplified by the activation of soluble guanylyl cyclase (sGC) and direct transnitrosation of 
cysteine thiols. Furthermore, reports showing that the cardiovascular [280; 281] and ventilatory 
[196] effects of S-nitrosocysteine are specific to the L-isoform suggest that transnitrosation may 
be stereoselective, as a consequence of the quaternary structure of target peptides [282]. 
B.1.4 Experimental Methods 
B.1.5 Cultured sheep pulmonary artery endothelial cells 
SPAEC were cultured from sheep pulmonary arteries obtained from a nearby slaughterhouse as 
previously described [128]. The SPAEC were grown in OptiMEM (GIBCO) supplemented with 
10% fetal bovine serum, 100U/ml penicillin, and 100 µg/ml streptomycin at 37°C in an 
atmosphere with 5% CO2. 
B.1.6 FRET-MT 
We followed the example of the Ca2+ indicator cameleon-1 [276] and constructed a chimera in 
which a yellow green fluorescent protein (GFP) variant (EYFP) and a cyan GFP variant (ECFP) 
   
 106 
were fused to the COOH and NH2 termini, respectively, of human MTIIA (FRET-MT) [60]. An 
E1- and E3-deleted replication- deficient adenoviral vector expressing this chimera was 
constructed as previously described [62] and cells were infected at a multiplicity of infection of 
50:1 for 24 h before imaging. 
B.1.7 Cyclic GMP reporter 
The cDNA encoding a fluorescent cGMP indicator consisting of cGMP protein kinase G Ia 
(PKGIa), minus residues 1–77, bracketed between cyan and yellow mutants of green fluorescent 
protein (cygnet-2) [277] was kindly provided by Roger Y. Tsien (University of California at San 
Diego). This reporter can detect changes in the activation of guanylyl cyclase indirectly via 
structural changes in cGMP-dependent protein kinase [277].  SPAEC that expressed cygnet-2 
were imaged 48 h after transfection with Lipofectamine Plus (Gibco BRL). 
B.1.8 Preparation of reagents 
The hydrochloride of S-nitroso-L-cysteine ethyl ester was prepared via direct S-nitrosation of the 
hydrochloride of L-cysteine ethyl ester with ethyl nitrite, as previously described [127].  D-
Cysteine ethyl ester was prepared as described by Baldwin [283]. Briefly, D-cysteine 
hydrochloride monohydrate was dissolved in dry distilled methanol, and HCl gas was bubbled 
through the solution for 2 h and then stirred at room temperature (48 h). The salient was rotor-
evaporated at 20°C to yield an oil which, upon titration with diethyl ether, yielded D-EtO-Cys-
SH (99%) as white crystals. The product’s purity was controlled by determination of free SH 
groups with 5,5’-dithiobis-2-nitrobenzoic acid [284] and by HPLC-EC [62].  Human hemoglobin 
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(Sigma–Aldrich) was dissolved in Hanks’ balanced salt solution (Gibco BRL) and reduced using 
a 10-fold excess of sodium ascorbate (Sigma–Aldrich). Oxyhemoglobin (HbO2) was purified by 
passing the solution over a Sephadex G-25 column and the concentration of HbO2 was measured 
at an absorbance of 
415 nm. Final concentrations of 100 µM HbO2 were used in the described experiments. 
B.1.9 Determination of nitrite concentration 
Two separate subcultures of SPAEC were exposed to 200 µM D- or L-SNCEE for 2 h. Nitrite 
accumulation in the culture supernatant was assayed in triplicate with a Greiss reaction [285]. 
Absorbance was measured at 550 nm and nitrite was quantified with NaNO2 as a standard. 
B.1.10 FRET detection 
Cells were bathed in Hanks’ balanced salt solution (Gibco BRL) containing 100 µM EDTA to 
chelate trace amounts of metal ions in the buffer and prevent extracellular decomposition of S-
nitrosothiol and imaged at 37°C using a thermocontrolled stage insert (Harvard Apparatus, Inc., 
Holliston, MA, USA). Images were obtained with a 40x oil immersion optic at 512  x 512 pixels 
using the confocal-based Zeiss spectral imaging system (LSM510 META; Carl Zeiss, Jena, 
Germany).  Cyan was excited at 458 nm (HFT 458).  Resolved fluorescence spectra at each pixel 
were detected by an array of eight spectrally separate photomultiplier tube elements within the 
META detection head and recorded on a voxel-by-voxel basis during scanning to generate a set 
of images, each corresponding to the fluorescence wavelength resolved at 10 nm intervals. Color 
separation of cyan and yellow emission spectra was determined from the resolved image using a 
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linear unmixing algorithm based on reference spectra obtained in cells expressing only cyan or 
yellow protein.  Images were collected at baseline and 1, 3, 6, and 9 min after addition of the 
relevant agonist. In separate control experiments, FRET was confirmed for the FRET-MT and 
cygnet-2 constructs by acceptor photobleaching (data not shown). 
B.2 RESULTS 
 
B.2.1 S-nitrosocysteine ethyl ester activates FRET-MT stereoselectively 
SPAEC were infected with an adenovirus encoding the cDNA for a GFP chimeric protein, 
consisting of the 6 kDa heavy metal binding protein MT, sandwiched between enhanced cyan 
and yellow fluorescent protein, as previously described [62; 119]. We have shown that this 
construct is sensitive to a variety of NO donors as well as endothelial nitric oxide synthase-
derived NO [62; 119]. We have now extended these findings using the spectral imaging 
approach for FRET detection, in combination with a novel membrane-permeant S-nitrosothiol, to 
provide further details regarding the biochemical nature of the nitrosative modifications of MT. 
Figure B.1 shows a single endothelial cell expressing the FRET-MT reporter after linear 
unmixing using calibration spectra for ECFP and EYFP.  
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Figure B 1 Cyan and yellow emissions at baseline and after application of L-SNCEE, in live endothelial 
cells that express the FRET-MT reporter.  Lung endothelial cells were infected with an adenoviral vector encoding 
the fluorescent FRET-MT reporter molecule.  FRET was detected in real time, using full spectral confocal imaging.  
The images illustrate the separation of the two emitted signals (cyan and yellow) after spectral unmixing based on 
individual calibration spectra for each protein.  The accompanying spectral report is represented in Fig. B 2A. After 
application of L-SNCEE (50 µM) there was an increase in the emission intensity of the donor (cyan) and a decrease 
in that of the acceptor (yellow).  The dual-color image at the bottom highlights this decrease in energy transfer. 
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These images therefore represent the separate contributions of the cyan and yellow emissions. 
The spectral report for this cell appears in Fig. B 2A and shows an increase in the peak emission 
intensity of the donor (cyan, ~485 nm) and a decrease in that of the acceptor (yellow, ~525 nm) 
after application of L-SNCEE (50 µM).  
 
Figure B 2 Spectral reports for individual endothelial cells expressing (A and B) FRET-MT or (C and D) 
cygnet-2.  L-SNCEE (50 µM) induced conformational changes in the FRET-MT reporter as shown by a decrease in 
energy transfer with an increase in the peak emission intensity of the donor (cyan, ~485nm) and a decrease in that of 
the acceptor (yellow, ~525nm) (A), whereas D-SNCEE (50 µM) had no appreciable effect on the FRET-MT 
reporter molecule (B).  In contrast, both L-SNCEE (C) and D-SNCEE (D) induced conformational changes in the 
cygnet-2 (cGMP) reporter. 
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In three subcultures of SPAEC expressing the FRET-MT reporter (three to five cells per 
experiment) the intramolecular FRET ratio was decreased on average by 34.1 ± 4.0% (SD) in 
response to L-SNCEE (Fig B 3).   
 
Figure B 3 Mean changes (± SD) in FRET, expressed as a percentage change from control, for both the 
cgnet-2 (cGMP) and the FRET-MT reporter molecules in response to the L- and D-stereoisomers of SNCEE.  The 
mean represents three experiments per condition (three to five cells per experiment). 
 
In separate experiments L-SNCEE-induced changes in FRET were reversed by 50 µM 
dithiothreitol (DTT; Fig.B 4).  
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Figure B 4 The effects of L-SNCEE on FRET-MT were reversed by dithiothreitol (DTT).  As shown by 
the spectral report from a single cell (left), L-SNCEE (50 µM) caused a decrease in the peak emission of the FRET 
donor (cyan, 458 nm) and an increase in the peak emission of the FRET acceptor (yellow, 525 nm).  Application of 
DTT (50 µM) reversed these effects.  Mean data (right) from seven cells in three separate experiments showed a 
significant decrease in FRET ratio (from 1.9 ±0.1 to 1.5 ± 0.1, p<0.05) after application of L-SNCEE and an 
increase in FRET ratio to baseline levels (1.8 ± 0.1, p>0.05) 6 min after DTT treatment. 
 
Such reversibility is suggestive of nitrosothiol-mediated modification of a cysteine residue(s) in 
MT. Furthermore, the effects of L-SNCEE on the FRET-MT reporter were not affected by HbO2 
(Fig. B 5), which would be expected to block any process involving •NO liberated by 
decomposition of nitrosothiol, but would not necessarily affect transnitrosation.  
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Figure B 5 The effects of L-SNCEE on FRET-MT were not affected by oxyhemoglobin.  Mean changes (± 
SD) in FRET, expressed as a percentage change from control, for both the cygnet-2 (cGMP) and the FRET-MT 
reporter molecules in response to L-SNCEE in the presence or absence of oxyhemoglobin (100 µM).  The mean 
represents three experiments per condition (three to five cells per experiment). 
 
In contrast to the effects of L-SNCEE on FRET-MT, there was no significant change in FRET in 
response to equimolar concentrations of D-SNCEE (Figs. B 2B and B 3). D- and L-SNCEE 
decomposed equally in cell-based assays, as determined by the accumulation of nitrite in EDTA-
free culture medium. In addition, both isoforms activated protein kinase G Ia to similar extents 
(Fig. B 3, see below), suggesting that the stereoselective effect was specific to MT. These 
combined results most likely reflected the trans-S-nitrosation of thiolate clusters of MT by L-
SNCEE. 
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B.2.2 S-nitrosocysteine ethyl ester activates the cGMP reporter cygnet 
SPAEC were transfected with cDNA encoding a fluorescent cGMP indicator (cygnet-2) 
consisting of cGMP-dependent PKGIa, minus residues 1–77, bracketed between cyan and yellow 
mutants of green fluorescent protein (kindly donated by Roger Y. Tsien, University of California 
at San Diego). cGMP induces conformational changes in PKGIa, detectable as decreases in 
FRET between the cyan and the yellow protein with the cygnet-2 reporter [277]. As shown in 
Fig. B 2C, L-SNCEE caused an increase in the peak emission intensity of the donor (cyan) and 
am decrease in that of the acceptor (yellow). This decrease in energy transfer was consistent with 
increases in cGMP, as previously shown with this FRET reporter in response to activation of 
soluble or particulate guanylyl cyclase by nitric oxide donors or C-type natriuretic peptide, 
respectively [277]. In contrast to the FRET-MT reporter molecule, cygnet-2 responded equally to 
both the L- and the D-stereoisoforms of S-nitrosocysteine, with decreases in the FRET ratio of 
18.1 ± 3.6 and 17.0 ± 7.0%, respectively (Figs. B 2D and B 3). A 10 min pretreatment of cells 
with 10 MM ODQ (1H-[1,2,4]-oxadiazolo[4,3-a] quinoxalin-1-one), a selective inhibitor of sGC, 
prevented the SNCEE-mediated changes in energy transfer (mean change in FRET ratio, 1.5 
±10.4%), demonstrating that these effects were dependent upon activation of sGC and resultant 
increases in cGMP. Cygnet-2 also responded effectively to the •NO donor PAPAnonate (100 
µM), with a mean decrease of 13.9 ± 1.2% in energy transfer. 
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B.3 DISCUSSION 
We observed (Figs. B 2A, B 2B, and B 3) stereospecific effects of the membrane-permeant 
forms of the D- and L-isoforms of SNCEE on the FRET-MT reporter. D- and L-SNCEE 
decomposed equally in cell-based assays, however, and effected comparable changes in the 
cGMP reporter cygnet-2, likely via activation of soluble guanylyl cyclase by formation of an Fe–
nitrosyl heme complex. L-SNCEE-induced changes in FRET-MT were reversible by DTT (Fig. 
B 4) and insensitive to extracellular oxyhemoglobin (Fig. B 5). These data corroborate our in 
vitro finding that NO can S-nitrosate MT [124] and provide spectral laser scanning confocal 
imaging (Fig.B 1) of FRET-based conformational changes in MT, consistent with direct 
transnitrosation of the protein. 
B.3.1 Transnitrosation of MT by SNCEE 
Putative mechanisms governing the stereoselective effects of bolus infusions of S-nitrosocysteine 
on vascular smooth muscle [280], and on CNS-mediated regulation of cardiovascular [281] and 
respiratory [196] activities, include stereospecific receptor and/or transporter interactions and 
stereoselective catabolism. Indeed the mechanisms governing these physiological effects are 
likely membrane-based because S-nitrosocysteine (SNC) is an unstable, hydrophilic compound 
that cannot efficiently cross membranes [127]. Many of the biological effects of exogenous 
application of SNC may therefore be attributed to its extracellular decomposition to •NO. In this 
report, however, we utilized the D- and L-stereoisomers of the lipophilic SNCEE, previously 
shown to be stable in solutions containing metal chelators and to accumulate inside human 
neutrophils [127]. The preferential effects of S-nitroso- L-cysteine on FRET-MT therefore might 
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suggest that the structure of the L-stereoisomer of SNCEE confers access to a critical cysteine 
residue(s) in the metallothionein protein and that the observed changes in energy transfer are via 
direct transnitrosation of MT. The reversal of L-SNCEE-mediated changes in FRET-MT by 
dithiothreitol provides further support for such nitrosative modifications to a cysteine residue(s) 
in MT, as DTT is reported to effectively remove thiol-bound NO groups from proteins [28; 286]. 
Alternatively, our methodology does not allow us to eliminate the possibility that a 
stereoselective mMino acid transport system, such as that recently described for SNC in PC12 
cells [287], may also contribute to the differing effects of L- and D-SNCEE on FRET-MT.  
We showed previously that FRET-MT was sensitive to bolus additions of buffer saturated 
with NO gas [60], whereas the present results show that •NO liberated from 
D-SNCEE had no effect on this construct. The apparent discrepancy is most likely explained by 
exposure of the cells to much higher •NO concentrations in these earlier reports, which, under 
aerobic conditions, can form reactive species capable of nitrosating MT [288]. These conclusions 
are supported by the in vitro data demonstrating the S-nitrosation of purified MT protein in the 
presence of NO donors [124]. In summary, the collective evidence suggests that L-SNCEE alters 
the conformation of FRET-MT via transnitrosation of MT cysteine(s); however, our evidence for 
S-nitrosation remains indirect and it is therefore possible that an alternative DTT reversible 
mechanism could explain these effects. 
Nitrosothiol-induced conformational changes in FRET-MT are consistent with previous 
reports both by our group [62; 124] and by others [56; 289] of NO-mediated release of metals 
from the thiolate clusters of metallothionein. The recent development of a FRET-based 
nanosensor based on the β-domain of recombinant metallothionein[289] may be useful in 
providing detailed structural information and quantification of zinc binding and release by the 
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reportedly more reactive [63; 290] of the two metal binding domains of MT in response to NO-
related species. Unlike the genetically encoded GFPbased probes, however, introduction of this 
fluorescently labeled FRET indicator [289] into living cells will require microinjection 
techniques and as yet remains untested. 
B.3.2 Activation of the cGMP reporter cygnet by SNCEE 
It is believed that S-nitrosothiols activate sGC via decomposition and formation of •NO [291; 
292; 293], which interacts with the iron–porphyrin center of the enzyme [294]. There has also 
been speculation regarding the direct activation of sGC by S-nitrosothiols [295; 296]. Our 
results, however, suggest that SNCEE activated PKGIa via an Fe–nitrosyl heme complex 
because cGMP production was sensitive to ODQ, which oxidizes the ferrous form of sGC to the 
ferric species and irreversibly inactivates the enzyme [297]. Furthermore, the scavenging of 
extracellular •NO by HbO2 blocked the L-SNCEE-mediated effects on the cygnet-2 reporter. It 
should be noted that the concentration of SNCEE (50 µM) used in these experiments may 
generate •NO concentrations that are in excess of the reported EC50 for sGC, which ranges from 
1 to 400 nM dependent upon the method of NO delivery [298]. If this is the case, then sGC could 
be maximally activated by only a small percentage of the total liberated •NO, and differences in 
the decomposition of L- versus D-SNCEE would not be detectable using our PKG-based FRET 
reporter. Pertinent to this discussion is the possibility that transnitrosation of MT occurs via 
breakdown of SNCEE and autoxidation of •NO. This chemistry will exhibit second-order 
dependence on the free [•NO], thus amplifying even modest differences in breakdown of L vs. 
D-SNCEE. However, our indirect determinations of •NO using the Greiss reaction to measure 
the stable decomposition products, NO3- and NO2-, indicate that L- and D-SNCEE generate 
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equivalent amounts of •NO under our experimental conditions. 
B.3.3 FRET detection 
FRET between GFP mutants offers a general mechanism to build genetically encoded indicators 
and to monitor dynamic molecular interactions in living systems.  This report describes the use 
of spectral confocalbased imaging for FRET detection that is capable of providing full spectral 
information for each voxel of the fluorescent image. This obviates problems of signal 
bleedthrough and channel cross talk and permits detection of small, but potentially biologically 
meaningful, changes in FRET that are extremely difficult to resolve reliably using the more 
traditional methods relying on band-pass filters. We found that FRET detection using this 
spectral imaging approach is a highly effective technique for detecting posttranslation protein 
modifications induced by NO-related species in living cells. 
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